| Year |
Citation |
Score |
| 2020 |
Stevenson M, Nath Banerjee H, Banerjee N, Rawat K, Chen L, Worthington M, Hodge S, Walker R, Verma M, Sarkar F, Mandal S. A health disparities study of MicroRNA-146a expression in prostate cancer samples derived from African American and European American patients. Journal of Solid Tumors. 10. PMID 32968471 DOI: 10.5430/Jst.V10N2P1 |
0.417 |
|
| 2019 |
Ahmad A, Dandawate P, Schruefer S, Padhye S, Sarkar FH, Schobert R, Biersack B. Pentafluorophenyl substitution of natural di(indol-3-yl)methane strongly enhances growth inhibition and apoptosis induction in various cancer cell lines. Chemistry & Biodiversity. PMID 30715794 DOI: 10.1002/Cbdv.201900028 |
0.439 |
|
| 2018 |
Kiselev VI, Ashrafyan LA, Muyzhnek EL, Gerfanova EV, Antonova IB, Aleshikova OI, Sarkar FH. A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study. Bmc Cancer. 18: 904. PMID 30236079 DOI: 10.1186/S12885-018-4792-9 |
0.411 |
|
| 2018 |
Sundararajan V, Sarkar FH, Ramasamy TS. Correction to: The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications. Cellular Oncology (Dordrecht). PMID 30047093 DOI: 10.1007/S13402-018-0396-2 |
0.381 |
|
| 2018 |
Sundararajan V, Sarkar FH, Ramasamy TS. The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications. Cellular Oncology (Dordrecht). PMID 29667069 DOI: 10.1007/S13402-018-0378-4 |
0.493 |
|
| 2018 |
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells". Cancer Letters. 423: 153. PMID 29606293 DOI: 10.1016/J.Canlet.2018.03.020 |
0.483 |
|
| 2018 |
Ramasamy TS, Velaithan V, Yeow Y, Sarkar FH. Stem Cells Derived From Amniotic Fluid: A Potential Pluripotent-Like Cell Source For Cellular Therapy? Current Stem Cell Research & Therapy. PMID 29336267 DOI: 10.2174/1574888X13666180115093800 |
0.321 |
|
| 2018 |
Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH. Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181]. Cancer Letters. 414: 313. PMID 29277381 DOI: 10.1016/J.Canlet.2017.11.030 |
0.436 |
|
| 2018 |
Banerjee HN, Sarkar F, Worthington M, Hodge S, Verma M, Mandal S. Abstract 3065: Role of noncoding RNA miR 146 alpha and let 7c in epithelial mesenchymal transition, proliferation, and cancer stem cell-like transformation analyzed by gene expression studies in a cohort of prostate cancer patients Cancer Research. 78: 3065-3065. DOI: 10.1158/1538-7445.Am2018-3065 |
0.464 |
|
| 2017 |
Luong D, Kesharwani P, Alsaab HO, Sau S, Padhye S, Sarkar FH, Iyer AK. Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers. Colloids and Surfaces. B, Biointerfaces. 157: 490-502. PMID 28658642 DOI: 10.1016/J.Colsurfb.2017.06.025 |
0.439 |
|
| 2017 |
Gawde KA, Kesharwani P, Sau S, Sarkar FH, Padhye S, Kashaw SK, Iyer AK. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. Journal of Colloid and Interface Science. 496: 290-299. PMID 28236692 DOI: 10.1016/J.Jcis.2017.01.092 |
0.347 |
|
| 2017 |
Banerjee HN, Hodge S, Kahan W, Mandal S, Weber D, Lapidus R, Sarkar F, Ghosh S. Abstract 120: A study of in vitro and in vivo effects of a novel peptide and rhenium compounds on prostate cancer Cancer Research. 77: 120-120. DOI: 10.1158/1538-7445.Am2017-120 |
0.483 |
|
| 2017 |
Ahmad A, Mahal K, Padhye S, Sarkar FH, Schobert R, Biersack B. New ferrocene modified lawsone Mannich bases with anti-proliferative activity against tumor cells Journal of Saudi Chemical Society. 21: 105-110. DOI: 10.1016/J.Jscs.2016.03.005 |
0.431 |
|
| 2016 |
Mahal K, Ahmad A, Schmitt F, Lockhauserbäumer J, Starz K, Pradhan R, Padhye S, Sarkar FH, Koko WS, Schobert R, Ersfeld K, Biersack B. Improved anticancer and antiparasitic activity of new lawsone Mannich bases. European Journal of Medicinal Chemistry. 126: 421-431. PMID 27912173 DOI: 10.1016/J.Ejmech.2016.11.043 |
0.304 |
|
| 2016 |
Gadgeel SM, Ali S, Philip PA, Ahmed F, Wozniak A, Sarkar FH. Retraction to: Response to dual blockade of epidermal growth factor receptor (EGFR) and cyclooxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor (Cancer, 10.1002/cncr.23100) Cancer. 122. PMID 27696404 DOI: 10.1002/Cncr.30217 |
0.4 |
|
| 2016 |
Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH. Retraction to: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines (Cancer, 10.1002/cncr.24250) Cancer. 122. PMID 27696403 DOI: 10.1002/Cncr.30218 |
0.451 |
|
| 2016 |
Banerjee HN, Boston A, Barfield A, Stevenson M, Sarkar FH, Giri D, Winstead A, Krause JA, Mandal SK. A Study of The Effects of Novel Rhenium Compounds on Pancreatic and Prostate Cancer Cell Lines. International Journal of Scientific Research (Ahmedabad, India). 5. PMID 27617235 |
0.32 |
|
| 2016 |
Luong D, Kesharwani P, Killinger BA, Moszczynska A, Sarkar FH, Padhye S, Rishi AK, Iyer AK. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. Journal of Colloid and Interface Science. 484: 33-43. PMID 27585998 DOI: 10.1016/J.Jcis.2016.08.061 |
0.491 |
|
| 2016 |
Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. PMID 27412558 DOI: 10.1007/s10549-016-3904-y |
0.463 |
|
| 2016 |
Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH. Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Breast Cancer Research and Treatment. PMID 27412557 DOI: 10.1007/S10549-016-3905-X |
0.508 |
|
| 2016 |
Li Y, Sarkar FH. MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer. International Journal of Biological Sciences. 12: 326-37. PMID 26929739 DOI: 10.7150/Ijbs.15017 |
0.446 |
|
| 2016 |
Ullah MF, Ahmad A, Bhat SH, Khan HY, Zubair H, Sarkar FH, Hadi SM. Simulating hypoxia-induced acidic environment in cancer cells facilitates mobilization and redox-cycling of genomic copper by daidzein leading to pro-oxidant cell death: implications for the sensitization of resistant hypoxic cancer cells to therapeutic challenges. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 26872803 DOI: 10.1007/S10534-016-9916-6 |
0.485 |
|
| 2016 |
Ahmad A, Li Y, Sarkar FH. The bounty of nature for changing the cancer landscape. Molecular Nutrition & Food Research. PMID 26799714 DOI: 10.1002/Mnfr.201500867 |
0.477 |
|
| 2016 |
Suresh R, Ali S, Ahmad A, Philip PA, Sarkar FH. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer. Advances in Experimental Medicine and Biology. 890: 57-74. PMID 26703799 DOI: 10.1007/978-3-319-24932-2_4 |
0.477 |
|
| 2016 |
Banerjee HN, Joyner J, Barfield A, Morris B, Bell D, Kahan W, Stevenson M, Crummity D, Prabhakaran K, Mandal S, Sarkar F. Abstract 4831: An investigation to study the role of novel rhenium compounds on onco miR's and oncogenes involved in epithelial mesenchymal transition of prostate cancer cell lines derived from African American and Caucasian patients Cancer Research. 76: 4831-4831. DOI: 10.1158/1538-7445.Am2016-4831 |
0.461 |
|
| 2016 |
Kong D, Li Y, Ahmad A, Bao B, Azmi A, Sarkar FH. Stem Cells and Cancer Journal of Cell Science and Therapy. 7: 413-433. DOI: 10.1007/978-1-4614-7876-8_16 |
0.491 |
|
| 2016 |
Muenzner JK, Ahmad A, Rothemund M, Schrüfer S, Padhye S, Sarkar FH, Schobert R, Biersack B. Ferrocene-substituted 3,3'-diindolylmethanes with improved anticancer activity Applied Organometallic Chemistry. DOI: 10.1002/Aoc.3452 |
0.423 |
|
| 2015 |
Wu RL, Ali S, Bandyopadhyay S, Alosh B, Hayek K, Daaboul MF, Winer I, Sarkar FH, Ali-Fehmi R. Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis. Journal of Cancer Science & Therapy. 7: 258-265. PMID 26819681 DOI: 10.4172/1948-5956.1000359 |
0.353 |
|
| 2015 |
Ali S, Dubaybo H, Brand RE, Sarkar FH. Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer. Journal of Cancer Science & Therapy. 7: 336-346. PMID 26819679 DOI: 10.4172/1948-5956.1000372 |
0.342 |
|
| 2015 |
Li Y, Sarkar FH. Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. PMID 26501150 DOI: 10.1159/000439307 |
0.368 |
|
| 2015 |
Farooqi AA, Li Y, Sarkar FH. The biological complexity of RKIP signaling in human cancers. Experimental & Molecular Medicine. 47: e185. PMID 26403261 DOI: 10.1038/Emm.2015.70 |
0.5 |
|
| 2015 |
Mahal K, Ahmad A, Sethi S, Resch M, Ficner R, Sarkar FH, Schobert R, Biersack B. Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cells. Cellular Oncology (Dordrecht). PMID 26358135 DOI: 10.1007/S13402-015-0243-7 |
0.33 |
|
| 2015 |
Kesharwani P, Banerjee S, Padhye S, Sarkar FH, Iyer AK. Hyaluronic acid engineered nano-micelles loaded with 3, 4-difluorobenzylidene curcumin for targeted killing of CD44+ stem-like pancreatic cancer cells. Biomacromolecules. PMID 26302089 DOI: 10.1021/Acs.Biomac.5B00941 |
0.383 |
|
| 2015 |
Sarkar FH. Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. PMID 26228733 DOI: 10.1159/000435814 |
0.457 |
|
| 2015 |
Ahmad A, Ginnebaugh KR, Yin S, Bollig-Fischer A, Reddy KB, Sarkar FH. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4. Bmc Cancer. 15: 540. PMID 26206152 DOI: 10.1186/S12885-015-1561-X |
0.409 |
|
| 2015 |
Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, Sethi S, Aboukameel A, Kiousis S, Zitron IM, Ebrahim SA, Polin LA, Sarkar FH, Bollig-Fischer A, Mittal S. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. Journal of Translational Medicine. 13: 227. PMID 26174772 DOI: 10.1186/S12967-015-0596-8 |
0.313 |
|
| 2015 |
Basak SK, Zinabadi A, Wu AW, Venkatesan N, Duarte VM, Kang JJ, Dalgard CL, Srivastava M, Sarkar FH, Wang MB, Srivatsan ES. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget. PMID 26098778 DOI: 10.18632/Oncotarget.4181 |
0.427 |
|
| 2015 |
Kesharwani P, Banerjee S, Padhye S, Sarkar FH, Iyer AK. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Colloids and Surfaces. B, Biointerfaces. 132: 138-45. PMID 26037703 DOI: 10.1016/J.Colsurfb.2015.05.007 |
0.355 |
|
| 2015 |
Ahmad A, Ginnebaugh KR, Sethi S, Chen W, Ali R, Mittal S, Sarkar FH. miR-20b is up-regulated in brain metastases from primary breast cancers. Oncotarget. 6: 12188-95. PMID 25893380 DOI: 10.18632/Oncotarget.3664 |
0.389 |
|
| 2015 |
Farooqi AA, Sarkar FH. Overview on the complexity of androgen receptor-targeted therapy for prostate cancer. Cancer Cell International. 15: 7. PMID 25705125 DOI: 10.1186/S12935-014-0153-1 |
0.37 |
|
| 2015 |
Ahmad A, Ginnebaugh KR, Li Y, Padhye SB, Sarkar FH. Molecular targets of naturopathy in cancer research: bridge to modern medicine. Nutrients. 7: 321-34. PMID 25569626 DOI: 10.3390/Nu7010321 |
0.427 |
|
| 2015 |
Li Y, Go VL, Sarkar FH. The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. Pancreas. 44: 1-10. PMID 25493373 DOI: 10.1097/Mpa.0000000000000257 |
0.489 |
|
| 2015 |
Kong D, Sethi S, Li Y, Chen W, Sakr WA, Heath E, Sarkar FH. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes. The Prostate. 75: 161-74. PMID 25307492 DOI: 10.1002/Pros.22901 |
0.395 |
|
| 2015 |
Sarkar FH. The Role of Exosomal Cargo in the Regulation of the Biological Complexity of Pancreatic Cancer Pancreatic Disorders & Therapy. 5. DOI: 10.4172/2165-7092.S5E002 |
0.454 |
|
| 2015 |
Li Y, Ahmad A, Sarkar FH. ASPP and iASPP: Implication in cancer development and progression. Cellular and Molecular Biology. 61: 2-8. DOI: 10.14715/Cmb/2015.61.6.2 |
0.483 |
|
| 2015 |
Stevenson M, Joyner J, Dildar K, Adedeji O, Prabhakaran K, Banerjee HN, Mandal S, Sarkar F. Abstract 4840: The role of miR-146a and novel Rhenium compounds on prostate cancer cell lines derived from African Americans and European American patients Cancer Research. 75: 4840-4840. DOI: 10.1158/1538-7445.Am2015-4840 |
0.373 |
|
| 2015 |
Bahassi EM, Furgason J, Koncar R, Michelhaugh S, Sarkar F, Mittal S, Sloan A, Barnholtz-Sloan J. GENO-05CHROMOTHRIPSIS IS A COMMON MECHANISM DRIVING GENOMIC REARRANGEMENTS IN GLIOBLASTOMA Neuro-Oncology. 17: v92.1-v92. DOI: 10.1093/Neuonc/Nov215.05 |
0.346 |
|
| 2015 |
Kesharwani P, Banerjee S, Gupta U, Mohd Amin MCI, Padhye S, Sarkar FH, Iyer AK. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics Materials Today. DOI: 10.1016/J.Mattod.2015.06.003 |
0.321 |
|
| 2015 |
Mbagu MK, Kebulu DN, Winstead A, Pramanik SK, Banerjee HN, Iwunze MO, Wachira JM, Greco GE, Haynes GK, Sehmer A, Sarkar FH, Ho DM, Pike RD, Mandal SK. Corrigendum to “Fac-tricarbonyl(pentylcarbonato)(α-diimine)rhenium complexes: One-pot synthesis, characterization, fluorescence studies, and cytotoxic activity against human MDA-MB-231 breast, CCl-227 colon and BxPC-3 pancreatic carcinoma cell lines” [Inorg. Chem. Commun. 21 (2012) 35–38] Inorganic Chemistry Communications. 56: 141. DOI: 10.1016/J.Inoche.2015.03.021 |
0.321 |
|
| 2015 |
Li Y, Sarkar FH. Targeting Epigenetically Deregulated miRNA by Nutraceuticals: Focusing on Cancer Prevention and Treatment Current Pharmacology Reports. 1: 1-10. DOI: 10.1007/S40495-015-0016-Z |
0.319 |
|
| 2014 |
Ullah MF, Bhat SH, Husain E, Abu-Duhier F, Hadi SM, Sarkar FH, Ahmad A. Pharmacological Intervention through Dietary Nutraceuticals in Gastrointestinal Neoplasia. Critical Reviews in Food Science and Nutrition. 0. PMID 25365584 DOI: 10.1080/10408398.2013.772091 |
0.436 |
|
| 2014 |
Bao B, Azmi AS, Ali S, Zaiem F, Sarkar FH. Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers. Annals of Translational Medicine. 2: 59. PMID 25333034 DOI: 10.3978/J.Issn.2305-5839.2014.06.05 |
0.505 |
|
| 2014 |
Ali S, Ahmad A, Aboukameel A, Ahmed A, Bao B, Banerjee S, Philip PA, Sarkar FH. Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling. Cancer Letters. 351: 134-42. PMID 24839931 DOI: 10.1016/J.Canlet.2014.05.013 |
0.338 |
|
| 2014 |
Dandawate P, Ahmad A, Deshpande J, Swamy KV, Khan EM, Khetmalas M, Padhye S, Sarkar F. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 24: 2900-4. PMID 24835626 DOI: 10.1016/J.Bmcl.2014.04.100 |
0.419 |
|
| 2014 |
Ginnebaugh KR, Ahmad A, Sarkar FH. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer. Expert Opinion On Therapeutic Targets. 18: 731-45. PMID 24758643 DOI: 10.1517/14728222.2014.909807 |
0.457 |
|
| 2014 |
Bao B, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Aboukameel A, Mohammad R, Van Buren E, Azmi AS, Sarkar FH. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer. Stem Cells and Development. 23: 1947-58. PMID 24734907 DOI: 10.1089/Scd.2013.0551 |
0.463 |
|
| 2014 |
Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, Back J, Sarkar FH. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. The Journal of Biological Chemistry. 289: 14520-33. PMID 24719318 DOI: 10.1074/Jbc.M113.532887 |
0.456 |
|
| 2014 |
Sethi S, Ali S, Sarkar FH. MicroRNAs in personalized cancer therapy Clinical Genetics. 86: 68-73. PMID 24635652 DOI: 10.1111/Cge.12362 |
0.313 |
|
| 2014 |
Tang J, Ahmad A, Sarkar FH. MicroRNAs in breast cancer therapy. Current Pharmaceutical Design. 20: 5268-74. PMID 24479805 DOI: 10.2174/1381612820666140128205239 |
0.406 |
|
| 2014 |
Sahin K, Orhan C, Tuzcu M, Muqbil I, Sahin N, Gencoglu H, Guler O, Padhye SB, Sarkar FH, Mohammad RM. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity. Biological Trace Element Research. 157: 156-63. PMID 24415068 DOI: 10.1007/S12011-014-9886-X |
0.305 |
|
| 2014 |
Li Y, Ahmad A, Kong D, Bao B, Sarkar FH. Recent progress on nutraceutical research in prostate cancer. Cancer Metastasis Reviews. 33: 629-40. PMID 24375392 DOI: 10.1007/S10555-013-9478-9 |
0.472 |
|
| 2014 |
Ahmad A, Li Y, Bao B, Kong D, Sarkar FH. Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. Molecular Nutrition & Food Research. 58: 79-86. PMID 24272883 DOI: 10.1002/Mnfr.201300528 |
0.425 |
|
| 2014 |
Khan HY, Zubair H, Faisal M, Ullah MF, Farhan M, Sarkar FH, Ahmad A, Hadi SM. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action. Molecular Nutrition & Food Research. 58: 437-46. PMID 24123728 DOI: 10.1002/Mnfr.201300417 |
0.434 |
|
| 2014 |
Ahmed A, Ali S, Sarkar FH. Advances in androgen receptor targeted therapy for prostate cancer. Journal of Cellular Physiology. 229: 271-6. PMID 24037862 DOI: 10.1002/Jcp.24456 |
0.398 |
|
| 2014 |
Bao B, Azmi AS, Li Y, Ahmad A, Ali S, Banerjee S, Kong D, Sarkar FH. Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness. Current Stem Cell Research & Therapy. 9: 22-35. PMID 23957937 DOI: 10.2174/1574888X113089990053 |
0.397 |
|
| 2014 |
Alian OM, Philip PA, Sarkar FH, Azmi AS. Systems biology approaches to pancreatic cancer detection, prevention and treatment. Current Pharmaceutical Design. 20: 73-80. PMID 23530496 DOI: 10.2174/138161282001140113124643 |
0.333 |
|
| 2014 |
Ullah MF, Ahmad A, Khan HY, Zubair H, Sarkar FH, Hadi SM. The prooxidant action of dietary antioxidants leading to cellular DNA breakage and anticancer effects: implications for chemotherapeutic action against cancer. Cell Biochemistry and Biophysics. 67: 431-8. PMID 22038302 DOI: 10.1007/S12013-011-9303-4 |
0.405 |
|
| 2014 |
Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar F, Wang Z. Xia, J.; et al., Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer. Int. J. Mol. Sci. 2012, 13, 9627–9641 International Journal of Molecular Sciences. 15: 14907-14908. DOI: 10.3390/Ijms150814907 |
0.373 |
|
| 2014 |
Azmi AS, Senapedis W, Baloglu E, Landesman Y, Kalid O, Aboukameel A, Bao B, Shacham S, Sarkar FH, Kauffman M, Mohammad RM. Novel PAK4 inhibitors for pancreatic cancer therapy. Journal of Clinical Oncology. 32: 233-233. DOI: 10.1200/Jco.2014.32.3_Suppl.233 |
0.475 |
|
| 2014 |
Ahmad A, Ginnebaugh K, Sarkar FH, Gadgeel SM. Role of Notch-1 in epithelial-to-mesenchymal transition-induced erlotinib resistance of non-small cell lung cancer (NSCLC) cells. Journal of Clinical Oncology. 32: e22136-e22136. DOI: 10.1200/Jco.2014.32.15_Suppl.E22136 |
0.426 |
|
| 2014 |
Bao E, Azmi A, Zhang E, Ali S, Ahmad A, Zaiem F, Bao B, Sarkar FH. Abstract 4351: Targeting miRNA-driven aggressive behavior of pancreatic cancer stem cells by a novel drug Cancer Research. 74: 4351-4351. DOI: 10.1158/1538-7445.Am2014-4351 |
0.466 |
|
| 2014 |
Basak SK, Zinabadi A, Venkatesan N, Duarte VM, Dalgard CL, Srivastava M, Wang MB, Sarkar FH, Srivatsan ES. Abstract 3909: Cisplatin resistant head and neck cancer cells are susceptible to growth inhibition by CDF curcumin Cancer Research. 74: 3909-3909. DOI: 10.1158/1538-7445.Am2014-3909 |
0.368 |
|
| 2014 |
Bao B, Azmi A, Ahmad A, Ali S, Li Y, Sarkar FH. Abstract 2364: Pancreatic cancer stem-like cells display aggressive behavior mediated through the activation of FoxQ1 Cancer Research. 74: 2364-2364. DOI: 10.1158/1538-7445.Am2014-2364 |
0.5 |
|
| 2014 |
Michelhaugh S, Guastella A, Varadarajan K, Polin L, Bollig-Fischer A, Sarkar F, Mittal S. PM-11 * DEVELOPMENT OF A HUMAN MENINGIOMA MOUSE XENOGRAFT MODEL WITH THE SPONTANEOUSLY IMMORTAL CELL LINE KCI-MENG1 Neuro-Oncology. 16: v171-v171. DOI: 10.1093/Neuonc/Nou268.11 |
0.395 |
|
| 2014 |
Gao J, Sarkar FH, Miele L, Wang Z. The Role of Notch Signaling Pathway in the Progression of Pancreatic Cancer Molecular Diagnostics and Treatment of Pancreatic Cancer. 75-89. DOI: 10.1016/B978-0-12-408103-1.00004-2 |
0.375 |
|
| 2014 |
Ullah MF, Bhat SH, Husain E, Abu-Duhier F, Hadi SM, Sarkar FH, Ahmad A. Cancer chemopreventive pharmacology of phytochemicals derived from plants of dietary and non-dietary origin: implication for alternative and complementary approaches Phytochemistry Reviews. 13: 811-833. DOI: 10.1007/S11101-014-9341-9 |
0.45 |
|
| 2013 |
Azmi AS, Sarkar FH, Hadi SM. Pro-oxidant activity of dietary chemopreventive agents: an under-appreciated anti-cancer property. F1000research. 2: 135. PMID 24358870 DOI: 10.12688/F1000Research.2-135.V1 |
0.363 |
|
| 2013 |
Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Daniel K, Deng G, Djeu J, Dou J, Hawk E, Jayaram B, Jia L, Joshi R, Kararala M, Karunagaran D, Kucuk O, ... ... Sarkar F, et al. Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival. Cancer Medicine. 2: 108-15. PMID 24279005 DOI: 10.1002/Cam4.42 |
0.411 |
|
| 2013 |
Sethi S, Ali S, Kong D, Philip PA, Sarkar FH. Clinical implication of microRNAs in molecular pathology. Clinics in Laboratory Medicine. 33: 773-86. PMID 24267185 DOI: 10.1016/J.Cll.2013.08.001 |
0.397 |
|
| 2013 |
Ahmad A, Maitah MY, Ginnebaugh KR, Li Y, Bao B, Gadgeel SM, Sarkar FH. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. Journal of Hematology & Oncology. 6: 77. PMID 24199791 DOI: 10.1186/1756-8722-6-77 |
0.809 |
|
| 2013 |
Li Y, Ma J, Qian X, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Regulation of EMT by Notch signaling pathway in tumor progression. Current Cancer Drug Targets. 13: 957-62. PMID 24168187 DOI: 10.2174/15680096113136660101 |
0.523 |
|
| 2013 |
Wu Q, Wang R, Yang Q, Hou X, Chen S, Hou Y, Chen C, Yang Y, Miele L, Sarkar FH, Chen Y, Wang Z. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway. Oncotarget. 4: 1999-2009. PMID 24158561 DOI: 10.18632/Oncotarget.1471 |
0.435 |
|
| 2013 |
Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, Sarkar FH, Brown ML, Dritschilo A, Rosen EM. DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proceedings of the National Academy of Sciences of the United States of America. 110: 18650-5. PMID 24127581 DOI: 10.1073/Pnas.1308206110 |
0.356 |
|
| 2013 |
Dandawate P, Padhye S, Ahmad A, Sarkar FH. Novel strategies targeting cancer stem cells through phytochemicals and their analogs. Drug Delivery and Translational Research. 3: 165-82. PMID 24076568 DOI: 10.1007/S13346-012-0079-X |
0.468 |
|
| 2013 |
Ma J, Xia J, Miele L, Sarkar FH, Wang Z. Notch Signaling Pathway in Pancreatic Cancer Progression. Pancreatic Disorders & Therapy. 3. PMID 24027656 DOI: 10.4172/2165-7092.1000114 |
0.532 |
|
| 2013 |
Azmi AS, Bollig-Fischer A, Bao B, Park BJ, Lee SH, Yong-Song G, Dyson G, Reddy CK, Sarkar FH, Mohammad RM. Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25. Bmc Systems Biology. 7: 85. PMID 24004452 DOI: 10.1186/1752-0509-7-85 |
0.332 |
|
| 2013 |
Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. European Journal of Cancer (Oxford, England : 1990). 49: 3914-23. PMID 23992642 DOI: 10.1016/J.Ejca.2013.07.148 |
0.517 |
|
| 2013 |
Li Y, Ahmad A, Kong D, Bao B, Sarkar FH. Targeting MicroRNAs for personalized cancer therapy. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. 22: 415-7. PMID 23948699 DOI: 10.1159/000353562 |
0.372 |
|
| 2013 |
Cao Z, Shang B, Zhang G, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochimica Et Biophysica Acta. 1836: 273-86. PMID 23933263 DOI: 10.1016/J.Bbcan.2013.08.001 |
0.518 |
|
| 2013 |
Ma J, Zhang Q, Chen S, Fang B, Yang Q, Chen C, Miele L, Sarkar FH, Xia J, Wang Z. Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1α accumulation via increased production of reactive oxygen species. Plos One. 8: e69485. PMID 23922721 DOI: 10.1371/Journal.Pone.0069485 |
0.507 |
|
| 2013 |
Roy S, Yu Y, Padhye SB, Sarkar FH, Majumdar AP. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. Plos One. 8: e68543. PMID 23894315 DOI: 10.1371/Journal.Pone.0068543 |
0.475 |
|
| 2013 |
Sethi S, Ali S, Philip PA, Sarkar FH. Clinical advances in molecular biomarkers for cancer diagnosis and therapy. International Journal of Molecular Sciences. 14: 14771-84. PMID 23863689 DOI: 10.3390/Ijms140714771 |
0.42 |
|
| 2013 |
Sethi S, Li Y, Sarkar FH. Regulating miRNA by natural agents as a new strategy for cancer treatment. Current Drug Targets. 14: 1167-74. PMID 23834152 DOI: 10.2174/13894501113149990189 |
0.393 |
|
| 2013 |
Ma J, Cheng L, Liu H, Zhang J, Shi Y, Zeng F, Miele L, Sarkar FH, Xia J, Wang Z. Genistein down-regulates miR-223 expression in pancreatic cancer cells Current Drug Targets. 14: 1150-1156. PMID 23834147 DOI: 10.2174/13894501113149990187 |
0.542 |
|
| 2013 |
Wang R, Ma J, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Functional role of miR-34 family in human cancer Current Drug Targets. 14: 1185-1191. PMID 23834144 DOI: 10.2174/13894501113149990191 |
0.464 |
|
| 2013 |
Ahmad A, Biersack B, Li Y, Bao B, Kong D, Ali S, Banerjee S, Sarkar FH. Perspectives on the role of isoflavones in prostate cancer. The Aaps Journal. 15: 991-1000. PMID 23824838 DOI: 10.1208/S12248-013-9507-1 |
0.467 |
|
| 2013 |
Afrasiabi Z, Stovall P, Finley K, Choudhury A, Barnes C, Ahmad A, Sarkar F, Vyas A, Padhye S. Targeting triple negative breast cancer cells by N3-substituted 9,10-phenanthrenequinone thiosemicarbazones and their metal complexes. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 114: 114-9. PMID 23770498 DOI: 10.1016/J.Saa.2013.04.122 |
0.346 |
|
| 2013 |
Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit 14.25. PMID 23744710 DOI: 10.1002/0471141755.Ph1425S61 |
0.519 |
|
| 2013 |
Zubair H, Khan HY, Sohail A, Azim S, Ullah MF, Ahmad A, Sarkar FH, Hadi SM. Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. Cell Death & Disease. 4: e660. PMID 23744360 DOI: 10.1038/Cddis.2013.172 |
0.371 |
|
| 2013 |
Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Reviews. 32: 623-42. PMID 23709120 DOI: 10.1007/S10555-013-9441-9 |
0.471 |
|
| 2013 |
Osman MA, Sarkar FH, Rodriguez-Boulan E. A molecular rheostat at the interface of cancer and diabetes. Biochimica Et Biophysica Acta. 1836: 166-76. PMID 23639840 DOI: 10.1016/J.Bbcan.2013.04.005 |
0.436 |
|
| 2013 |
Yusufi M, Banerjee S, Mohammad M, Khatal S, Venkateswara Swamy K, Khan EM, Aboukameel A, Sarkar FH, Padhye S. Synthesis, characterization and anti-tumor activity of novel thymoquinone analogs against pancreatic cancer Bioorganic and Medicinal Chemistry Letters. 23: 3101-3104. PMID 23562242 DOI: 10.1016/J.Bmcl.2013.03.003 |
0.465 |
|
| 2013 |
Wang S, Wu Y, Hou Y, Guan X, Castelvetere MP, Oblak JJ, Banerjee S, Filtz TM, Sarkar FH, Chen X, Jena BP, Li C. CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth. Translational Oncology. 6: 216-25. PMID 23544174 DOI: 10.1593/Tlo.13133 |
0.465 |
|
| 2013 |
Yu Y, Sarkar FH, Majumdar AP. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens. Translational Oncology. 6: 180-6. PMID 23544170 DOI: 10.1593/Tlo.12397 |
0.486 |
|
| 2013 |
Zhang G, Yang P, Guo P, Miele L, Sarkar FH, Wang Z, Zhou Q. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer. Biochimica Et Biophysica Acta. 1836: 49-59. PMID 23523716 DOI: 10.1016/J.Bbcan.2013.03.001 |
0.476 |
|
| 2013 |
Yin S, Xu L, Bonfil RD, Banerjee S, Sarkar FH, Sethi S, Reddy KB. Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer. Molecular Cancer Therapeutics. 12: 491-8. PMID 23445611 DOI: 10.1158/1535-7163.Mct-12-1090 |
0.482 |
|
| 2013 |
Tang J, Salama R, Gadgeel SM, Sarkar FH, Ahmad A. Erlotinib resistance in lung cancer: current progress and future perspectives. Frontiers in Pharmacology. 4: 15. PMID 23407898 DOI: 10.3389/Fphar.2013.00015 |
0.423 |
|
| 2013 |
Thakur A, Schalk D, Tomaszewski E, Kondadasula SV, Yano H, Sarkar FH, Lum LG. Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway. Journal of Translational Medicine. 11: 35. PMID 23394575 DOI: 10.1186/1479-5876-11-35 |
0.459 |
|
| 2013 |
Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy? Antioxidants & Redox Signaling. 19: 139-50. PMID 23391445 DOI: 10.1089/Ars.2013.5233 |
0.348 |
|
| 2013 |
Parasramka MA, Ali S, Banerjee S, Deryavoush T, Sarkar FH, Gupta S. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. Molecular Nutrition & Food Research. 57: 235-48. PMID 23293055 DOI: 10.1002/Mnfr.201200297 |
0.428 |
|
| 2013 |
Ahmad A, Biersack B, Li Y, Kong D, Bao B, Schobert R, Padhye SB, Sarkar FH. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. Anti-Cancer Agents in Medicinal Chemistry. 13: 1014-24. PMID 23272911 DOI: 10.2174/18715206113139990117 |
0.473 |
|
| 2013 |
Ahmad A, Biersack B, Li Y, Kong D, Bao B, Schobert R, Padhye SB, Sarkar FH. Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry. 13: 1002-13. PMID 23272910 DOI: 10.2174/18715206113139990078 |
0.381 |
|
| 2013 |
Wu Q, Hou X, Xia J, Qian X, Miele L, Sarkar FH, Wang Z. Emerging roles of PDGF-D in EMT progression during tumorigenesis Cancer Treatment Reviews. 39: 640-646. PMID 23261166 DOI: 10.1016/J.Ctrv.2012.11.006 |
0.47 |
|
| 2013 |
Azmi AS, Bao GW, Gao J, Mohammad RM, Sarkar FH. Network insights into the genes regulated by hepatocyte nuclear factor 4 in response to drug induced perturbations: a review. Current Drug Discovery Technologies. 10: 147-54. PMID 23237677 DOI: 10.2174/1570163811310020007 |
0.355 |
|
| 2013 |
Tan Y, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Systems biology approaches in identifying the targets of natural compounds for cancer therapy Current Drug Discovery Technologies. 10: 139-146. PMID 23237676 DOI: 10.2174/1570163811310020006 |
0.485 |
|
| 2013 |
Wang Z, Wan L, Zhong J, Inuzuka H, Liu P, Sarkar FH, Wei W. Cdc20: a potential novel therapeutic target for cancer treatment. Current Pharmaceutical Design. 19: 3210-4. PMID 23151139 DOI: 10.2174/1381612811319180005 |
0.564 |
|
| 2013 |
Vyas A, Dandawate P, Padhye S, Ahmad A, Sarkar F. Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Current Pharmaceutical Design. 19: 2047-69. PMID 23116312 |
0.348 |
|
| 2013 |
Azmi AS, Aboukameel A, Bao B, Sarkar FH, Philip PA, Kauffman M, Shacham S, Mohammad RM. Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice. Gastroenterology. 144: 447-56. PMID 23089203 DOI: 10.1053/J.Gastro.2012.10.036 |
0.477 |
|
| 2013 |
Wang Z, Ali S, Banerjee S, Bao B, Li Y, Azmi AS, Korc M, Sarkar FH. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. Journal of Cellular Physiology. 228: 556-62. PMID 22806240 DOI: 10.1002/Jcp.24162 |
0.552 |
|
| 2013 |
Ali AS, Ahmad A, Ali S, Bao B, Philip PA, Sarkar FH. The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis. Journal of Cellular Physiology. 228: 36-42. PMID 22689345 DOI: 10.1002/Jcp.24127 |
0.405 |
|
| 2013 |
Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Letters. 338: 94-100. PMID 22445908 DOI: 10.1016/J.Canlet.2012.03.018 |
0.469 |
|
| 2013 |
Vyas A, Dandawate P, Padhye S, Ahmad A, Sarkar F. Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties Current Pharmaceutical Design. 19: 2047-2069. DOI: 10.2174/138161213805289309 |
0.456 |
|
| 2013 |
Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, Narayan S. Effect of NSC-124854 on TMZ-mediated cell growth inhibition of MMR-proficient and MMR-deficient colon cancer cell lines in culture. Plos One. DOI: 10.1371/Journal.Pone.0016691.T001 |
0.459 |
|
| 2013 |
Hillman GG, Singh-Gupta V, Hoogstra DJ, Abernathy L, Rakowski J, Yunker C, Sarkar FH, Konski AA, Lonardo F, Joiner MC. Abstract LB-358: Soy improves radiotherapy for lung tumors and mitigates radiation-induced injury to lung tissue. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-358 |
0.305 |
|
| 2013 |
Sethi S, Ahmad A, Mittal S, Ali R, Chen W, Sarkar FH. Abstract 5327: Upregulation of miR-10b associated with breast cancer metastasis to brain . Cancer Research. 73: 5327-5327. DOI: 10.1158/1538-7445.Am2013-5327 |
0.405 |
|
| 2013 |
Azmi AS, Bollig-Fisher A, Bao B, Joon-Park B, Lee S, Song G, Mohammad RM, Sarkar FH. Abstract 5234: Network interrogations on SNAIL inhibitor GN-25 induced perturbations in HMLE-SNAIL cell line models. Cancer Research. 73: 5234-5234. DOI: 10.1158/1538-7445.Am2013-5234 |
0.452 |
|
| 2013 |
Banerjee HN, Vaughan D, Medley J, Hyman G, Krauss C, Parson C, Mandal S, Olczak P, Mbagu M, Kebulu D, Pramanik S, Sarkar F. Abstract 4485: Anticancer properties of novel rhenium compounds against human cancer cell lines. Cancer Research. 73: 4485-4485. DOI: 10.1158/1538-7445.Am2013-4485 |
0.313 |
|
| 2013 |
Bao B, Ali SS, Azmi A, Ahmad A, Kong D, Li Y, Banerjee S, Aboukameel A, Padhye S, Sarkar F. Abstract 3296: The loss of miR-34a and activation of Notch-1 leads to aggressiveness of pancreatic cancer cells, which could be attenuated by CDF. Cancer Research. 73: 3296-3296. DOI: 10.1158/1538-7445.Am2013-3296 |
0.43 |
|
| 2013 |
Reddy KB, Yin S, Daniel RB, Banerjee S, Sarkar F, Sethi S. Abstract 241: Tumor initiating cells and FZD8 play a major role in drugresistance and tumor progression in triple negative breast cancer. Cancer Research. 73: 241-241. DOI: 10.1158/1538-7445.Am2013-241 |
0.489 |
|
| 2013 |
Yu Y, Sarkar FH, Majumdar APN. Abstract 2077: Downregulation of miR-21 induces differentiation of chemo-resistant colon cancer cells and enhances susceptibility to therapeutic regimens. Cancer Research. 73: 2077-2077. DOI: 10.1158/1538-7445.Am2013-2077 |
0.475 |
|
| 2013 |
Sethi S, Ahmad A, Ali-Fehmi R, Mittal S, Dyson G, Sarkar F. Abstract P4-15-07: MicroRNA signature of breast cancer brain metastasis for novel targeted therapies Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-15-07 |
0.383 |
|
| 2013 |
Sethi S, Ahmad A, Ali-Fehmi R, Mittal S, Sarkar F. Molecular Micrornas, Target Genes and Signaling Pathways of Breast Cancer Brain Metastasis: Implications in Clinical Medicine American Journal of Clinical Pathology. 140: A150-A150. DOI: 10.1093/Ajcp/140.Suppl1.150 |
0.425 |
|
| 2013 |
Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GPV, Sarkar FH. Regulation of FOXO3a/β-catenin/GSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Journal of Biological Chemistry. 288: 34755-34755. DOI: 10.1074/Jbc.A113.701978 |
0.522 |
|
| 2013 |
Yu Y, Sarkar F, Majumdar AP. Tu1593 Downregulation of miR-21 Induces Differentiation of Chemo-Resistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)62962-5 |
0.415 |
|
| 2013 |
Bao B, Ali S, Banerjee S, Sarkar F. Hypoxia-induced aggressiveness of pancreatic cancer (PC) cells is due to increased expression of VEGF, IL-6 and miR-21, which could be attenuated by CDF Pancreatology. 13: e16. DOI: 10.1016/J.Pan.2012.12.108 |
0.382 |
|
| 2013 |
Azmi A, Shacham S, Aboukameel A, Bao B, Kauffman M, Sarkar F, Mohammad R. Targeting nuclear export machinery for pancreatic cancer therapy Pancreatology. 13: e15. DOI: 10.1016/J.Pan.2012.12.106 |
0.396 |
|
| 2013 |
Ali S, Ahmad A, Aboukameel A, Ahmed A, Bao B, Philip P, Sarkar F. The miR-146a regulates EGFR signaling both in vitro and in a mouse model of pancreatic cancer in vivo Pancreatology. 13: e13. DOI: 10.1016/J.Pan.2012.12.099 |
0.365 |
|
| 2013 |
Afrasiabi Z, Almudhafar R, Xiao D, Sinn E, Choudhury A, Ahmad A, Vyas A, Sarkar F, Padhye S. Metal-based anticancer agents: Targeting androgen-dependent and androgen-independent prostate and COX-positive pancreatic cancer cells by phenanthrenequinone semicarbazone and its metal complexes Transition Metal Chemistry. 38: 665-673. DOI: 10.1007/S11243-013-9735-3 |
0.463 |
|
| 2012 |
Philip PA, Saleh H, Ali S, Chen W, Palazzolo P, Sethi S, Sarkar FH. MicroRNA analysis of fine-needle aspirates from pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 200. PMID 27983161 DOI: 10.1200/Jco.2012.30.4_Suppl.200 |
0.373 |
|
| 2012 |
Xia J, Sarkar FH, Wang Z. Emerging Role of MicroRNA in Pancreatic Cancer. Pancreatic Disorders & Therapy. 2: e114. PMID 24851195 DOI: 10.4172/2165-7092.1000E114 |
0.492 |
|
| 2012 |
Muqbil I, Bao GW, El-Kharraj R, Shah M, Mohammad RM, Sarkar FH, Azmi AS. Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy. Journal of Stem Cell Research & Therapy. PMID 24319631 DOI: 10.4172/2157-7633.S7-005 |
0.45 |
|
| 2012 |
Tan Y, Miele L, Sarkar FH, Wang Z. Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer. Pancreatic Disorders & Therapy. 2: 1000e128. PMID 23378937 DOI: 10.4172/2165-7092.1000E128 |
0.432 |
|
| 2012 |
Raffoul JJ, Kucuk O, Sarkar FH, Hillman GG. Dietary agents in cancer chemoprevention and treatment. Journal of Oncology. 2012: 749310. PMID 23316231 DOI: 10.1155/2012/749310 |
0.479 |
|
| 2012 |
Bao B, Ali S, Ahmad A, Azmi AS, Li Y, Banerjee S, Kong D, Sethi S, Aboukameel A, Padhye SB, Sarkar FH. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. Plos One. 7: e50165. PMID 23272057 DOI: 10.1371/Journal.Pone.0050165 |
0.431 |
|
| 2012 |
Wang Z, Inuzuka H, Zhong J, Liu P, Sarkar FH, Sun Y, Wei W. Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2. Oncotarget. 3: 1294-300. PMID 23230084 DOI: 10.18632/Oncotarget.740 |
0.485 |
|
| 2012 |
Tang J, Ahmad A, Sarkar FH. The role of microRNAs in breast cancer migration, invasion and metastasis. International Journal of Molecular Sciences. 13: 13414-37. PMID 23202960 DOI: 10.3390/Ijms131013414 |
0.394 |
|
| 2012 |
Haq S, Ali S, Mohammad R, Sarkar FH. The complexities of epidemiology and prevention of gastrointestinal cancers. International Journal of Molecular Sciences. 13: 12556-72. PMID 23202913 DOI: 10.3390/Ijms131012556 |
0.435 |
|
| 2012 |
Thakur A, Lum LG, Schalk D, Azmi A, Banerjee S, Sarkar FH, Mohommad R. Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. Plos One. 7: e47520. PMID 23185240 DOI: 10.1371/Journal.Pone.0047520 |
0.499 |
|
| 2012 |
Wu Q, Miele L, Sarkar FH, Wang Z. The Role of EMT in Pancreatic Cancer Progression. Pancreatic Disorders & Therapy. 2. PMID 23145368 DOI: 10.4172/2165-7092.1000E121 |
0.576 |
|
| 2012 |
Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, Banerjee S, Kong D, Sarkar FH. Targeting CSC-related miRNAs for cancer therapy by natural agents. Current Drug Targets. 13: 1858-68. PMID 23140295 DOI: 10.2174/138945012804545515 |
0.383 |
|
| 2012 |
Xia J, Duan Q, Ahmad A, Bao B, Banerjee S, Shi Y, Ma J, Geng J, Chen Z, Rahman KM, Miele L, Sarkar FH, Wang Z. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Current Drug Targets. 13: 1750-6. PMID 23140286 DOI: 10.2174/138945012804545597 |
0.534 |
|
| 2012 |
Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH. Perspectives on medicinal properties of plumbagin and its analogs. Medicinal Research Reviews. 32: 1131-58. PMID 23059762 DOI: 10.1002/Med.20235 |
0.38 |
|
| 2012 |
Chen D, Banerjee S, Cui QC, Kong D, Sarkar FH, Dou QP. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo. Plos One. 7: e47186. PMID 23056607 DOI: 10.1371/Journal.Pone.0047186 |
0.496 |
|
| 2012 |
Kong D, Ahmad A, Bao B, Li Y, Banerjee S, Sarkar FH. Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells. Plos One. 7: e45045. PMID 23024790 DOI: 10.1371/Journal.Pone.0045045 |
0.468 |
|
| 2012 |
Roy S, Levi E, Majumdar AP, Sarkar FH. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. Journal of Hematology & Oncology. 5: 58. PMID 22992310 DOI: 10.1186/1756-8722-5-58 |
0.352 |
|
| 2012 |
Ahmad A, Sarkar SH, Aboukameel A, Ali S, Biersack B, Seibt S, Li Y, Bao B, Kong D, Banerjee S, Schobert R, Padhye SB, Sarkar FH. Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling. Carcinogenesis. 33: 2450-6. PMID 22971573 DOI: 10.1093/Carcin/Bgs290 |
0.545 |
|
| 2012 |
Bao B, Ahmad A, Kong D, Ali S, Azmi AS, Li Y, Banerjee S, Padhye S, Sarkar FH. Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. Plos One. 7: e43726. PMID 22952749 DOI: 10.1371/Journal.Pone.0043726 |
0.482 |
|
| 2012 |
Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar FH, Wang Z. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. International Journal of Molecular Sciences. 13: 9627-41. PMID 22949821 DOI: 10.3390/Ijms13089627 |
0.554 |
|
| 2012 |
Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. British Journal of Cancer. 107: 1354-60. PMID 22929886 DOI: 10.1038/Bjc.2012.383 |
0.348 |
|
| 2012 |
Bao B, Ahmad A, Li Y, Azmi AS, Ali S, Banerjee S, Kong D, Sarkar FH. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. Expert Opinion On Therapeutic Targets. 16: 1041-54. PMID 22877147 DOI: 10.1517/14728222.2012.714774 |
0.368 |
|
| 2012 |
Ahmad A, Sarkar SH, Bitar B, Ali S, Aboukameel A, Sethi S, Li Y, Bao B, Kong D, Banerjee S, Padhye SB, Sarkar FH. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells. Molecular Cancer Therapeutics. 11: 2193-201. PMID 22821148 DOI: 10.1158/1535-7163.Mct-12-0232-T |
0.496 |
|
| 2012 |
Li Y, Kong D, Ahmad A, Bao B, Dyson G, Sarkar FH. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics. 7: 940-9. PMID 22805767 DOI: 10.4161/Epi.21236 |
0.328 |
|
| 2012 |
Biersack B, Ahmad A, Sarkar FH, Schobert R. Coinage metal complexes against breast cancer. Current Medicinal Chemistry. 19: 3949-56. PMID 22780959 DOI: 10.2174/092986712802002482 |
0.381 |
|
| 2012 |
Ji X, Wang Z, Sarkar FH, Gupta SV. Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway. Anticancer Research. 32: 2647-55. PMID 22753722 |
0.526 |
|
| 2012 |
Wang Z, Zhong J, Inuzuka H, Gao D, Shaik S, Sarkar FH, Wei W. An evolving role for DEPTOR in tumor development and progression. Neoplasia (New York, N.Y.). 14: 368-75. PMID 22745583 DOI: 10.1593/Neo.12542 |
0.508 |
|
| 2012 |
Azmi AS, Sarkar FH. Prostate cancer stem cells: molecular characterization for targeted therapy. Asian Journal of Andrology. 14: 659-60. PMID 22728671 DOI: 10.1038/Aja.2012.62 |
0.461 |
|
| 2012 |
Xia J, Chen C, Chen Z, Miele L, Sarkar FH, Wang Z. Targeting pancreatic cancer stem cells for cancer therapy. Biochimica Et Biophysica Acta. 1826: 385-99. PMID 22728049 DOI: 10.1016/J.Bbcan.2012.06.002 |
0.583 |
|
| 2012 |
Azmi AS, Mohammad RM, Sarkar FH. Can network pharmacology rescue neutraceutical cancer research? Drug Discovery Today. 17: 807-9. PMID 22727577 DOI: 10.1016/J.Drudis.2012.06.008 |
0.35 |
|
| 2012 |
Wang Z, Wei W, Sarkar FH. miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer. Cancer Discovery. 2: 489-91. PMID 22684455 DOI: 10.1158/2159-8290.Cd-12-0177 |
0.48 |
|
| 2012 |
Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, Wei W. Tumor suppressor functions of FBW7 in cancer development and progression. Febs Letters. 586: 1409-18. PMID 22673505 DOI: 10.1016/J.Febslet.2012.03.017 |
0.519 |
|
| 2012 |
Soubani O, Ali AS, Logna F, Ali S, Philip PA, Sarkar FH. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis. 33: 1563-71. PMID 22637745 DOI: 10.1093/Carcin/Bgs189 |
0.358 |
|
| 2012 |
Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochimica Et Biophysica Acta. 1826: 272-96. PMID 22579961 DOI: 10.1016/J.Bbcan.2012.04.008 |
0.406 |
|
| 2012 |
Dandawate P, Khan E, Padhye S, Gaba H, Sinha S, Deshpande J, Venkateswara Swamy K, Khetmalas M, Ahmad A, Sarkar FH. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 22: 3104-8. PMID 22483392 DOI: 10.1016/J.Bmcl.2012.03.060 |
0.439 |
|
| 2012 |
Ma YC, Shi C, Zhang YN, Wang LG, Liu H, Jia HT, Zhang YX, Sarkar FH, Wang ZS. The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells. Plos One. 7: e33414. PMID 22479394 DOI: 10.1371/Journal.Pone.0033414 |
0.495 |
|
| 2012 |
Kong D, Heath E, Chen W, Cher ML, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, ... Sarkar FH, et al. Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM. Plos One. 7: e33729. PMID 22442719 DOI: 10.1371/Journal.Pone.0033729 |
0.456 |
|
| 2012 |
Ji X, Wang Z, Geamanu A, Goja A, Sarkar FH, Gupta SV. Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. International Journal of Cancer. 131: 2668-77. PMID 22438124 DOI: 10.1002/Ijc.27549 |
0.518 |
|
| 2012 |
Claudino WM, Goncalves PH, di Leo A, Philip PA, Sarkar FH. Metabolomics in cancer: a bench-to-bedside intersection. Critical Reviews in Oncology/Hematology. 84: 1-7. PMID 22429650 DOI: 10.1016/J.Critrevonc.2012.02.009 |
0.422 |
|
| 2012 |
Hassan O, Ahmad A, Sethi S, Sarkar FH. Recent updates on the role of microRNAs in prostate cancer. Journal of Hematology & Oncology. 5: 9. PMID 22417299 DOI: 10.1186/1756-8722-5-9 |
0.326 |
|
| 2012 |
Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis. Plos One. 7: e33011. PMID 22412975 DOI: 10.1371/Journal.Pone.0033011 |
0.344 |
|
| 2012 |
Wang G, Wang Z, Sarkar FH, Wei W. Targeting prostate cancer stem cells for cancer therapy. Discovery Medicine. 13: 135-42. PMID 22369972 |
0.442 |
|
| 2012 |
Dandawate PR, Vyas A, Ahmad A, Banerjee S, Deshpande J, Swamy KV, Jamadar A, Dumhe-Klaire AC, Padhye S, Sarkar FH. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharmaceutical Research. 29: 1775-86. PMID 22322899 DOI: 10.1007/S11095-012-0700-1 |
0.362 |
|
| 2012 |
Vyas A, Syeda K, Ahmad A, Padhye S, Sarkar FH. Perspectives on medicinal properties of mangiferin. Mini Reviews in Medicinal Chemistry. 12: 412-25. PMID 22303941 DOI: 10.2174/138955712800493870 |
0.303 |
|
| 2012 |
Muqbil I, Beck FW, Bao B, Sarkar FH, Mohammad RM, Hadi SM, Azmi AS. Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrol. Current Pharmaceutical Design. 18: 1645-54. PMID 22288443 DOI: 10.2174/138161212799958567 |
0.415 |
|
| 2012 |
Wang Z, Fukushima H, Inuzuka H, Wan L, Liu P, Gao D, Sarkar FH, Wei W. Skp2 is a promising therapeutic target in breast cancer. Frontiers in Oncology. 1. PMID 22279619 DOI: 10.3389/Fonc.2011.00057 |
0.539 |
|
| 2012 |
Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH. RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Cancer Letters. 319: 173-181. PMID 22261338 DOI: 10.1016/J.Canlet.2012.01.013 |
0.312 |
|
| 2012 |
Li Y, Maitah MY, Ahmad A, Kong D, Bao B, Sarkar FH. Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opinion On Therapeutic Targets. 16: 49-66. PMID 22243133 DOI: 10.1517/14728222.2011.617367 |
0.831 |
|
| 2012 |
Ali S, Banerjee S, Logna F, Bao B, Philip PA, Korc M, Sarkar FH. Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer. Journal of Cellular Physiology. 227: 3373-80. PMID 22213426 DOI: 10.1002/Jcp.24036 |
0.32 |
|
| 2012 |
Wang Z, Inuzuka H, Fukushima H, Wan L, Gao D, Shaik S, Sarkar FH, Wei W. Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. Embo Reports. 13: 36-43. PMID 22157894 DOI: 10.1038/Embor.2011.231 |
0.486 |
|
| 2012 |
Bao B, Thakur A, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Ali S, Lum LG, Sarkar FH. The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent. Biochimica Et Biophysica Acta. 1825: 160-72. PMID 22155217 DOI: 10.1016/J.Bbcan.2011.11.002 |
0.435 |
|
| 2012 |
Singh-Gupta V, Banerjee S, Yunker CK, Rakowski JT, Joiner MC, Konski AA, Sarkar FH, Hillman GG. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer. Cancer Letters. 318: 86-92. PMID 22155105 DOI: 10.1016/J.Canlet.2011.12.006 |
0.416 |
|
| 2012 |
Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, Sarkar FH. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Research. 72: 335-45. PMID 22108826 DOI: 10.1158/0008-5472.Can-11-2182 |
0.558 |
|
| 2012 |
Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 5: 355-64. PMID 22086681 DOI: 10.1158/1940-6207.Capr-11-0299 |
0.569 |
|
| 2012 |
Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, Majumdar AP. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 33: 68-76. PMID 22072622 DOI: 10.1093/Carcin/Bgr246 |
0.402 |
|
| 2012 |
Wang Z, Gao D, Fukushima H, Inuzuka H, Liu P, Wan L, Sarkar FH, Wei W. Skp2: a novel potential therapeutic target for prostate cancer. Biochimica Et Biophysica Acta. 1825: 11-7. PMID 21963805 DOI: 10.1016/J.Bbcan.2011.09.002 |
0.539 |
|
| 2012 |
Shamim U, Hanif S, Albanyan A, Beck FW, Bao B, Wang Z, Banerjee S, Sarkar FH, Mohammad RM, Hadi SM, Azmi AS. Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer. Journal of Cellular Physiology. 227: 1493-500. PMID 21678400 DOI: 10.1002/Jcp.22865 |
0.505 |
|
| 2012 |
Ahmad A, Sarkar FH, Maitah M, Ali S, Sethi S, Aboukameel A, Gadgeel SM. Effect of GDC-0449, a hedgehog (Hh) pathway inhibitor, on tumor activity and on erlotinib and cisplatin in a xenograft model of non-small cell lung cancer (NSCLC) with activated Hh pathway. Journal of Clinical Oncology. 30: e21057-e21057. DOI: 10.1200/Jco.2012.30.15_Suppl.E21057 |
0.807 |
|
| 2012 |
Heath EI, Hwang C, Cher ML, Heilbrun LK, Powell I, Menon M, Li J, Chitale D, Gupta N, Sethi S, Bolton S, Smith DW, Sarkar FH. The effects of BR-DIM (BioResponse 3, 3’-Diindolylmethane) administered pre-prostatectomy on the androgen receptor (AR). Journal of Clinical Oncology. 30: 1560-1560. DOI: 10.1200/Jco.2012.30.15_Suppl.1560 |
0.301 |
|
| 2012 |
Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Abstract B66: Targeting bone remodeling by isoflavone and 3,3′-diindolylmethane in the context of prostate cancer bone metastasis Cancer Research. 72: B66-B66. DOI: 10.1158/1538-7445.Prca2012-B66 |
0.38 |
|
| 2012 |
Azmi AS, Mohammad RM, Sarkar FH. Abstract A1: SNAIL inhibitor GN-25 induces MET through Global Reprograming of EMT Network Genes: a Systems and Network Analysis Cancer Research. 72. DOI: 10.1158/1538-7445.Csb12-A1 |
0.379 |
|
| 2012 |
Bao B, Ali S, Ahmad A, Azmi AS, Banerjee S, Kong D, Li Y, Padhye S, Sarkar FH. Abstract 5196: CDF inhibits cell migration by inactivating cancer stem cell markers, and expression of VEGF, IL-6 and miR-21 in human pancreatic and prostate cancer cells under hypoxic condition Cancer Research. 72: 5196-5196. DOI: 10.1158/1538-7445.Am2012-5196 |
0.513 |
|
| 2012 |
Ali SS, Saleh H, Sethi S, Sarkar FH, Philip PA. Abstract 5027: MicroRNA profiling of diagnostic fine needle aspirates of pancreatic cancer preserved as formalin-fixed paraffin-embedded cell blocks Cancer Research. 72: 5027-5027. DOI: 10.1158/1538-7445.Am2012-5027 |
0.363 |
|
| 2012 |
Sethi S, Kong D, Sakr W, Land S, Dyson G, Sarkar F. Abstract 4599: Comprehensive molecular oncogenomic profiling & miRNA analysis of prostate cancer Cancer Research. 72: 4599-4599. DOI: 10.1158/1538-7445.Am2012-4599 |
0.389 |
|
| 2012 |
Banerjee S, Ali S, Azmi A, Kong D, Ahmad A, Bao B, Sarkar FH. Abstract 2698: Improved therapeutic activity of Isoflavone-G2535 and Docetaxel combination in hormone refractory prostate cancer Cancer Research. 72: 2698-2698. DOI: 10.1158/1538-7445.Am2012-2698 |
0.493 |
|
| 2012 |
Ahmad A, Aboukameel A, Ali S, Li Y, Bao B, Kong D, Banerjee S, Sarkar FH. Abstract 2578: Anticancer action of garcinolin vitroandin vivois mediated through inhibition of STAT-3 signaling Cancer Research. 72: 2578-2578. DOI: 10.1158/1538-7445.Am2012-2578 |
0.537 |
|
| 2012 |
Ali S, Soubani O, Ali A, Logna F, Philip P, Sarkar F. Abstract B22: Re-expression of miR-200 by natural agents regulates the expression of PTEN and MT1-MMP in pancreatic cancer Clinical Cancer Research. 18: B22-B22. DOI: 10.1158/1078-0432.Mechres-B22 |
0.358 |
|
| 2012 |
Ahmad A, Reddy KB, Sarkar FH. Abstract A1: Functional significance of miR-10b in tamoxifen resistance of breast cancer cells Clinical Cancer Research. 18: A1-A1. DOI: 10.1158/1078-0432.Mechres-A1 |
0.376 |
|
| 2012 |
Vyas A, Patitungkho S, Jamadar A, Adsule S, Padhye S, Ahmad A, Sarkar FH. ATRA-hydrazonate derivatives and their copper complexes against hormone-dependent (MCF-7), hormone-independent (MDA-MB-231and BT-20) breast cancer and androgen-independent (PC3) prostate cancer cell lines Inorganic Chemistry Communications. 23: 17-20. DOI: 10.1016/J.Inoche.2012.05.027 |
0.485 |
|
| 2012 |
Azam M, Warad I, Al-Resayes S, Shakir M, Ullah MF, Ahmad A, Sarkar FH. A novel Ru(II) complex derived from hydroxydiamine as a potential antitumor agent: Synthesis and Structural Characterization Inorganic Chemistry Communications. 20: 252-258. DOI: 10.1016/J.Inoche.2012.03.019 |
0.391 |
|
| 2011 |
Maitah M, Ali S, LoRusso P, Sarkar FH, Gadgeel SM. The role of GDC-0449, a hedgehog (Hh) pathway inhibitor, on epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) cells lines and its effect on erlotinib and cisplatin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10537. PMID 28021873 DOI: 10.1200/Jco.2011.29.15_Suppl.10537 |
0.832 |
|
| 2011 |
Heath EI, Hwang C, Cher ML, Heilbrun LK, Powell I, Menon M, Li J, Heath M, Sethi S, Sarkar FH. A biomarker trial of BR-DIM (BioResponse 3,3'- Diindolylmethane) in patients with prostate cancer who undergo prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15185. PMID 28020958 DOI: 10.1200/Jco.2011.29.15_Suppl.E15185 |
0.335 |
|
| 2011 |
Muqbil I, Masood A, Sarkar FH, Mohammad RM, Azmi AS. Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents. Cancers. 3: 428-45. PMID 24212623 DOI: 10.3390/Cancers3010428 |
0.352 |
|
| 2011 |
Li Y, Kong D, Bao B, Ahmad A, Sarkar FH. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. Nutrients. 3: 877-96. PMID 22200028 DOI: 10.3390/Nu3100877 |
0.539 |
|
| 2011 |
Hillman GG, Singh-Gupta V, Runyan L, Yunker CK, Rakowski JT, Sarkar FH, Miller S, Gadgeel SM, Sethi S, Joiner MC, Konski AA. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 329-36. PMID 22079530 DOI: 10.1016/J.Radonc.2011.10.020 |
0.423 |
|
| 2011 |
Thakur A, Schalk D, Sarkar SH, Al-Khadimi Z, Sarkar FH, Lum LG. A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells. Cancer Immunology, Immunotherapy : Cii. 61: 497-509. PMID 21971587 DOI: 10.1007/S00262-011-1116-1 |
0.367 |
|
| 2011 |
Azmi AS, Ali S, Banerjee S, Bao B, Maitah MN, Padhye S, Philip PA, Mohammad RM, Sarkar FH. Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism. American Journal of Translational Research. 3: 374-82. PMID 21904657 |
0.833 |
|
| 2011 |
Schobert R, Seibt S, Mahal K, Ahmad A, Biersack B, Effenberger-Neidnicht K, Padhye S, Sarkar FH, Mueller T. Cancer Selective Metallocenedicarboxylates of the Fungal Cytotoxin Illudin M Journal of Medicinal Chemistry. 54: 6177-6182. PMID 21848340 DOI: 10.1021/Jm200359N |
0.406 |
|
| 2011 |
Sethi S, Sarkar FH, Ahmed Q, Bandyopadhyay S, Nahleh ZA, Semaan A, Sakr W, Munkarah A, Ali-Fehmi R. Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma. Translational Oncology. 4: 222-6. PMID 21804917 DOI: 10.1593/Tlo.10244 |
0.459 |
|
| 2011 |
Ali AS, Ali S, Ahmad A, Bao B, Philip PA, Sarkar FH. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. 12: 1050-62. PMID 21767342 DOI: 10.1111/J.1467-789X.2011.00906.X |
0.339 |
|
| 2011 |
Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic. Mutation Research. 728: 47-66. PMID 21703360 DOI: 10.1016/J.Mrrev.2011.06.001 |
0.574 |
|
| 2011 |
Li Y, Kong D, Wang Z, Ahmad A, Bao B, Padhye S, Sarkar FH. Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 4: 1495-506. PMID 21680704 DOI: 10.1158/1940-6207.Capr-11-0077 |
0.555 |
|
| 2011 |
Wang Z, Banerjee S, Ahmad A, Li Y, Azmi AS, Gunn JR, Kong D, Bao B, Ali S, Gao J, Mohammad RM, Miele L, Korc M, Sarkar FH. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. Plos One. 6: e20537. PMID 21673986 DOI: 10.1371/Journal.Pone.0020537 |
0.442 |
|
| 2011 |
Kong D, Li Y, Wang Z, Sarkar FH. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? Cancers. 3: 716-29. PMID 21643534 DOI: 10.3390/Cancers30100716 |
0.559 |
|
| 2011 |
Azmi AS, Banerjee S, Ali S, Wang Z, Bao B, Beck FW, Maitah M, Choi M, Shields TF, Philip PA, Sarkar FH, Mohammad RM. Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. Oncotarget. 2: 378-92. PMID 21623005 DOI: 10.18632/Oncotarget.269 |
0.804 |
|
| 2011 |
Li X, Kaplun A, Lonardo F, Heath E, Sarkar FH, Irish J, Sakr W, Sheng S. HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells. Molecular Cancer Research : McR. 9: 733-45. PMID 21622623 DOI: 10.1158/1541-7786.Mcr-10-0505 |
0.394 |
|
| 2011 |
Ahmad A, Wang Z, Wojewoda C, Ali R, Kong D, Maitah MY, Banerjee S, Bao B, Padhye S, Sarkar FH. Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling. Frontiers in Bioscience (Elite Edition). 3: 1483-92. PMID 21622152 DOI: 10.2741/E349 |
0.846 |
|
| 2011 |
Ji X, Wang Z, Geamanu A, Sarkar FH, Gupta SV. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation. Journal of Cellular Biochemistry. 112: 2773-83. PMID 21598300 DOI: 10.1002/Jcb.23184 |
0.603 |
|
| 2011 |
Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Anticancer Research. 31: 1105-13. PMID 21508353 |
0.506 |
|
| 2011 |
Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. Journal of Cellular Biochemistry. 112: 2296-306. PMID 21503965 DOI: 10.1002/Jcb.23150 |
0.561 |
|
| 2011 |
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Letters. 307: 26-36. PMID 21463919 DOI: 10.1016/J.Canlet.2011.03.012 |
0.541 |
|
| 2011 |
Hillman GG, Singh-Gupta V, Al-Bashir AK, Yunker CK, Joiner MC, Sarkar FH, Abrams J, Haacke EM. Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumor. Translational Oncology. 4: 110-21. PMID 21461174 DOI: 10.1593/Tlo.10274 |
0.323 |
|
| 2011 |
Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philip PA, Sarkar FH. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. Plos One. 6: e17850. PMID 21408027 DOI: 10.1371/Journal.Pone.0017850 |
0.588 |
|
| 2011 |
Azmi AS, Beck FW, Sarkar FH, Mohammad RM. Network perspectives on HDM2 inhibitor chemotherapy combinations. Current Pharmaceutical Design. 17: 640-52. PMID 21391913 DOI: 10.2174/138161211795222612 |
0.35 |
|
| 2011 |
Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, Sarkar FH, Raz A. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells Cancer Research. 71: 3400-3409. PMID 21389093 DOI: 10.1158/0008-5472.Can-10-0965 |
0.48 |
|
| 2011 |
Singh-Gupta V, Joiner MC, Runyan L, Yunker CK, Sarkar FH, Miller S, Gadgeel SM, Konski AA, Hillman GG. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 688-98. PMID 21325978 DOI: 10.1097/Jto.0B013E31821034Ae |
0.441 |
|
| 2011 |
Patitungkho S, Adsule S, Dandawate P, Padhye S, Ahmad A, Sarkar FH. Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 21: 1802-6. PMID 21316236 DOI: 10.1016/J.Bmcl.2011.01.061 |
0.473 |
|
| 2011 |
Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, Narayan S. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer. Plos One. 6: e16691. PMID 21311763 DOI: 10.1371/Journal.Pone.0016691 |
0.423 |
|
| 2011 |
Liao S, Xia J, Chen Z, Zhang S, Ahmad A, Miele L, Sarkar FH, Wang Z. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. Journal of Cellular Biochemistry. 112: 1055-65. PMID 21308734 DOI: 10.1002/Jcb.23019 |
0.57 |
|
| 2011 |
Xu L, Yin S, Banerjee S, Sarkar F, Reddy KB. Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells. Molecular Cancer Therapeutics. 10: 550-7. PMID 21252285 DOI: 10.1158/1535-7163.Mct-10-0571 |
0.473 |
|
| 2011 |
Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH. Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. Plos One. 6: e16068. PMID 21249152 DOI: 10.1371/Journal.Pone.0016068 |
0.828 |
|
| 2011 |
Dou D, Ahmad A, Yang H, Sarkar FH. Tumor cell growth inhibition is correlated with levels of capsaicin present in hot peppers. Nutrition and Cancer. 63: 272-81. PMID 21240831 DOI: 10.1080/01635581.2011.523497 |
0.432 |
|
| 2011 |
Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, Majumdar AP. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharmaceutical Research. 28: 827-38. PMID 21161336 DOI: 10.1007/S11095-010-0336-Y |
0.469 |
|
| 2011 |
Bao B, Wang Z, Li Y, Kong D, Ali S, Banerjee S, Ahmad A, Sarkar FH. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica Et Biophysica Acta. 1815: 135-46. PMID 21129444 DOI: 10.1016/J.Bbcan.2010.11.003 |
0.447 |
|
| 2011 |
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Sarkar FH. Pancreatic cancer: understanding and overcoming chemoresistance. Nature Reviews. Gastroenterology & Hepatology. 8: 27-33. PMID 21102532 DOI: 10.1038/Nrgastro.2010.188 |
0.571 |
|
| 2011 |
Azmi AS, Philip PA, Beck FWJ, Wang Z, Banerjee S, Wang S, Yang D, Sarkar FH, Mohammad RM. MI-219-zinc combination: A new paradigm in MDM2 inhibitor-based therapy Oncogene. 30: 117-126. PMID 20818437 DOI: 10.1038/Onc.2010.403 |
0.457 |
|
| 2011 |
Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Emerging Bcl-2 inhibitors for the treatment of cancer. Expert Opinion On Emerging Drugs. 16: 59-70. PMID 20812891 DOI: 10.1517/14728214.2010.515210 |
0.529 |
|
| 2011 |
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. Journal of Cellular Biochemistry. 112: 78-88. PMID 20658545 DOI: 10.1002/Jcb.22770 |
0.601 |
|
| 2011 |
Nautiyal J, Banerjee S, Kanwar SS, Yu Y, Patel BB, Sarkar FH, Majumdar AP. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. International Journal of Cancer. 128: 951-61. PMID 20473900 DOI: 10.1002/Ijc.25410 |
0.504 |
|
| 2011 |
Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Breast Cancer Research and Treatment. 126: 15-25. PMID 20379844 DOI: 10.1007/S10549-010-0883-2 |
0.509 |
|
| 2011 |
El-Rayes BF, Philip PA, Sarkar FH, Shields AF, Ferris AM, Hess K, Kaseb AO, Javle MM, Varadhachary GR, Wolff RA, Abbruzzese JL. A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. Investigational New Drugs. 29: 694-9. PMID 20107864 DOI: 10.1007/S10637-010-9386-6 |
0.475 |
|
| 2011 |
Sethi S, Sarkar FH. Evolving Concept of Cancer Stem Cells: Role of Micro-RNAs and their Implications in Tumor Aggressiveness Journal of Carcinogenesis & Mutagenesis. 2012: 1-8. DOI: 10.4172/2157-2518.S1-005 |
0.364 |
|
| 2011 |
Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, Majumdar APN. Abstract 5381: A novel strategy to eliminate chemoresistant colon cancer cells Cancer Research. 71: 5381-5381. DOI: 10.1158/1538-7445.Am2011-5381 |
0.526 |
|
| 2011 |
Azmi AS, Philip PA, Choi M, Shields AF, Sarkar FH, Mohammad RM. Abstract 4910: Unveiling the role of network and systems biology in pancreatic cancer drug discovery Cancer Research. 71: 4910-4910. DOI: 10.1158/1538-7445.Am2011-4910 |
0.443 |
|
| 2011 |
Azmi AS, Padhye S, Banerjee S, Aboukameel A, Sarkar FH, Mohammad RM. Abstract 3706: Novel analogs of dietary thymoquinone with superior bioavailability and anti-tumor activity against GI cancers Cancer Research. 71: 3706-3706. DOI: 10.1158/1538-7445.Am2011-3706 |
0.52 |
|
| 2011 |
Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, Narayan S. Abstract 3524: Structure-based molecular docking of DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer Cancer Research. 71: 3524-3524. DOI: 10.1158/1538-7445.Am2011-3524 |
0.454 |
|
| 2011 |
Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH. Abstract 3364: Upregulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells Cancer Research. 71: 3364-3364. DOI: 10.1158/1538-7445.Am2011-3364 |
0.305 |
|
| 2011 |
Wang Z, Banerjee S, Ahmad A, Azmi AS, Bao B, Ali S, Mohammad RM, Miele L, Korc M, Sarkar FH. Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways Cancer Research. 71: 2385-2385. DOI: 10.1158/1538-7445.Am2011-2385 |
0.532 |
|
| 2011 |
Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philp PA, Sarkar FH. Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin Cancer Research. 71: 173-173. DOI: 10.1158/1538-7445.Am2011-173 |
0.584 |
|
| 2011 |
Ali S, Almhanna K, Chen W, Philip PA, Sarkar FH. Abstract 154: miRNAs in plasma of pancreatic cancer patients Cellular and Molecular Biology. 71: 154-154. DOI: 10.1158/1538-7445.Am2011-154 |
0.321 |
|
| 2011 |
Hillman G, Singh-Gupta V, Runyan L, Sethi S, Yunker C, Sarkar F, Miller S, Gadgeel S, Joiner M, Konski A. Differential Role of Soy Isoflavones in Radiotherapy of Lung Cancer: Augmenting Tumor Response and Protecting Normal Tissue International Journal of Radiation Oncology*Biology*Physics. 81: S736. DOI: 10.1016/J.Ijrobp.2011.06.1314 |
0.376 |
|
| 2011 |
Singh-Gupta V, Banerjee S, Sarkar F, Runyan L, Yunker C, Rakowski J, Joiner M, Konski A, Hillman G. B-DIM Inhibits Androgen Receptor Activation and Potentiates Radiation Effect in Hormone Refractory Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S741. DOI: 10.1016/J.Ijrobp.2011.06.1224 |
0.371 |
|
| 2010 |
Li Y, VandenBoom TG, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells. Cancer Research. 70: 5703. PMID 25242818 DOI: 10.1158/1538-7445.Am10-5703 |
0.519 |
|
| 2010 |
Ullah MF, Ahmad A, Zubair H, Khan HY, Wang Z, Sarkar FH, Hadi SM. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Molecular Nutrition & Food Research. 55: 553-9. PMID 21462322 DOI: 10.1002/Mnfr.201000329 |
0.561 |
|
| 2010 |
Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Molecular Cancer Therapeutics. 9: 3137-44. PMID 21041384 DOI: 10.1158/1535-7163.Mct-10-0642 |
0.473 |
|
| 2010 |
Prasad AS, Bao B, Beck FW, Sarkar FH. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB. Nutrition (Burbank, Los Angeles County, Calif.). 27: 816-23. PMID 21035309 DOI: 10.1016/J.Nut.2010.08.010 |
0.328 |
|
| 2010 |
Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, Cher ML, Andic F, Rossi PJ, Kucuk O. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutrition and Cancer. 62: 996-1000. PMID 20924975 DOI: 10.1080/01635581.2010.509839 |
0.333 |
|
| 2010 |
Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH, Mohammad RM. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutrition and Cancer. 62: 938-46. PMID 20924969 DOI: 10.1080/01635581.2010.509832 |
0.609 |
|
| 2010 |
Banerjee S, Kong D, Azmi AS, Wang Z, Ahmad A, Sethi S, Sarkar FH. Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. International Journal of Cancer. 128: 1240-50. PMID 20824697 DOI: 10.1002/Ijc.25658 |
0.539 |
|
| 2010 |
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. Plos One. 5: e12445. PMID 20805998 DOI: 10.1371/Journal.Pone.0012445 |
0.578 |
|
| 2010 |
Padhye S, Ahmad A, Oswal N, Dandawate P, Rub RA, Deshpande J, Swamy KV, Sarkar FH. Fluorinated 2'-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities. Bioorganic & Medicinal Chemistry Letters. 20: 5818-21. PMID 20729081 DOI: 10.1016/J.Bmcl.2010.07.128 |
0.421 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Kong D. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Reviews. 29: 383-94. PMID 20711635 DOI: 10.1007/S10555-010-9233-4 |
0.563 |
|
| 2010 |
Sarkar FH. Nutraceuticals and cancer. Preface. Cancer Metastasis Reviews. 29: 381-2. PMID 20703893 DOI: 10.1007/S10555-010-9243-2 |
0.447 |
|
| 2010 |
Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, Sarkar FH. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 109-18. PMID 20692200 DOI: 10.1016/J.Drup.2010.07.001 |
0.51 |
|
| 2010 |
Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Sarkar FH. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica Et Biophysica Acta. 1806: 258-67. PMID 20600632 DOI: 10.1016/J.Bbcan.2010.06.001 |
0.532 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Kong D. Novel targets for prostate cancer chemoprevention. Endocrine-Related Cancer. 17: R195-212. PMID 20576802 DOI: 10.1677/Erc-10-0074 |
0.554 |
|
| 2010 |
Kong L, Deng Z, Zhao Y, Wang Y, Sarkar FH, Zhang Y. Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells. Medical Oncology (Northwood, London, England). 28: 1495-506. PMID 20532678 DOI: 10.1007/S12032-010-9583-3 |
0.506 |
|
| 2010 |
Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Du J, Patel BB, Sarkar FH, Rishi AK, Mohammad RM, Majumdar AP. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells. Molecular Cancer Therapeutics. 9: 1503-14. PMID 20515951 DOI: 10.1158/1535-7163.Mct-10-0019 |
0.462 |
|
| 2010 |
Wang Z, Li Y, Sarkar FH. Notch signaling proteins: legitimate targets for cancer therapy. Current Protein & Peptide Science. 11: 398-408. PMID 20491628 DOI: 10.2174/138920310791824039 |
0.478 |
|
| 2010 |
Sarkar FH. (Part I) Recent trends in anti-cancer drug discovery. Mini Reviews in Medicinal Chemistry. 10: 357-8. PMID 20482491 DOI: 10.2174/138955710791330927 |
0.373 |
|
| 2010 |
Wang Z, Ahmad A, Li Y, Kong D, Azmi AS, Banerjee S, Sarkar FH. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochimica Et Biophysica Acta. 1806: 122-30. PMID 20434526 DOI: 10.1016/J.Bbcan.2010.04.003 |
0.466 |
|
| 2010 |
Azmi AS, Philip PA, Zafar SF, Sarkar FH, Mohammad RM. PAR-4 as a possible new target for pancreatic cancer therapy. Expert Opinion On Therapeutic Targets. 14: 611-20. PMID 20426700 DOI: 10.1517/14728222.2010.487066 |
0.449 |
|
| 2010 |
Banerjee S, Azmi AS, Padhye S, Singh MW, Baruah JB, Philip PA, Sarkar FH, Mohammad RM. Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer Pharmaceutical Research. 27: 1146-1158. PMID 20422266 DOI: 10.1007/S11095-010-0145-3 |
0.467 |
|
| 2010 |
Sarkar FH. Current trends in the chemoprevention of cancer. Pharmaceutical Research. 27: 945-9. PMID 20401521 DOI: 10.1007/S11095-010-0146-2 |
0.416 |
|
| 2010 |
Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, Wang Z, Philip PA, Sarkar FH. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Research. 70: 3606-17. PMID 20388782 DOI: 10.1158/0008-5472.Can-09-4598 |
0.521 |
|
| 2010 |
Azmi AS, Philip PA, Almhanna K, Beck FW, Sarkar FH, Mohammad RM. MDM2 inhibitors for pancreatic cancer therapy. Mini Reviews in Medicinal Chemistry. 10: 518-26. PMID 20377522 DOI: 10.2174/138955710791384054 |
0.425 |
|
| 2010 |
Padhye S, Chavan D, Pandey S, Deshpande J, Swamy KV, Sarkar FH. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini Reviews in Medicinal Chemistry. 10: 372-87. PMID 20370702 DOI: 10.2174/138955710791330891 |
0.345 |
|
| 2010 |
Azmi AS, Philip PA, Aboukameel A, Wang Z, Banerjee S, Zafar SF, Goustin AS, Almhanna K, Yang D, Sarkar FH, Mohammad RM. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. Current Cancer Drug Targets. 10: 319-31. PMID 20370686 DOI: 10.2174/156800910791190229 |
0.533 |
|
| 2010 |
Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, Li Y, Sarkar FH. FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharmaceutical Research. 27: 1159-68. PMID 20354770 DOI: 10.1007/S11095-010-0106-X |
0.568 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Padhye S. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Current Pharmaceutical Design. 16: 1801-12. PMID 20345353 DOI: 10.2174/138161210791208956 |
0.549 |
|
| 2010 |
Singh-Gupta V, Zhang H, Yunker CK, Ahmad Z, Zwier D, Sarkar FH, Hillman GG. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy. Pharmaceutical Research. 27: 1115-27. PMID 20309614 DOI: 10.1007/S11095-010-0107-9 |
0.396 |
|
| 2010 |
Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharmaceutical Research. 27: 1027-41. PMID 20306121 DOI: 10.1007/S11095-010-0105-Y |
0.521 |
|
| 2010 |
Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 57-66. PMID 20236855 DOI: 10.1016/J.Drup.2010.02.001 |
0.506 |
|
| 2010 |
Ali S, Banerjee S, Schaffert JM, El-Rayes BF, Philip PA, Sarkar FH. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. Journal of Cellular Biochemistry. 110: 171-81. PMID 20213764 DOI: 10.1002/Jcb.22523 |
0.449 |
|
| 2010 |
Azmi AS, Aboukameel A, Banerjee S, Wang Z, Mohammad M, Wu J, Wang S, Yang D, Philip PA, Sarkar FH, Mohammad RM. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function. European Journal of Cancer (Oxford, England : 1990). 46: 1122-31. PMID 20156675 DOI: 10.1016/J.Ejca.2010.01.015 |
0.505 |
|
| 2010 |
Li Y, Vandenboom TG, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research. 70: 1486-95. PMID 20124483 DOI: 10.1158/0008-5472.Can-09-2792 |
0.576 |
|
| 2010 |
Ahmad A, Wang Z, Ali R, Maitah MY, Kong D, Banerjee S, Padhye S, Sarkar FH. Apoptosis-inducing effect of garcinol is mediated by NF-kappaB signaling in breast cancer cells. Journal of Cellular Biochemistry. 109: 1134-41. PMID 20108249 DOI: 10.1002/Jcb.22492 |
0.838 |
|
| 2010 |
Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. Journal of Cellular Biochemistry. 109: 726-36. PMID 20052673 DOI: 10.1002/Jcb.22451 |
0.578 |
|
| 2010 |
Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Current Drug Targets. 11: 745-51. PMID 20041844 DOI: 10.2174/138945010791170860 |
0.491 |
|
| 2010 |
Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treatment Reviews. 36: 151-6. PMID 20022709 DOI: 10.1016/J.Ctrv.2009.11.006 |
0.522 |
|
| 2010 |
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Letters. 292: 141-8. PMID 20022691 DOI: 10.1016/J.Canlet.2009.11.012 |
0.445 |
|
| 2010 |
Wang Z, Li Y, Sarkar FH. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression. Current Stem Cell Research & Therapy. 5: 74-80. PMID 19951255 DOI: 10.2174/157488810790442813 |
0.573 |
|
| 2010 |
Banerjee S, Choi M, Aboukameel A, Wang Z, Mohammad M, Chen J, Yang D, Sarkar FH, Mohammad RM. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. Pancreas. 39: 323-31. PMID 19823097 DOI: 10.1097/Mpa.0B013E3181Bb95E7 |
0.547 |
|
| 2010 |
Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. 122: 337-46. PMID 19813088 DOI: 10.1007/S10549-009-0572-1 |
0.585 |
|
| 2010 |
Ahmad A, Kong D, Wang Z, Sarkar SH, Banerjee S, Sarkar FH. Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. Journal of Cellular Biochemistry. 108: 916-25. PMID 19693769 DOI: 10.1002/Jcb.22323 |
0.564 |
|
| 2010 |
Almhanna K, Azmi AS, Sarkar FH, Philip PA, Yang D, Wang S, Mohammad R. Evaluation of a novel MDM-2 inhibitor with cisplatin/oxalipatin for the treatment of pancreatic cancer independent of p53 mutational status. Journal of Clinical Oncology. 28: e13613-e13613. DOI: 10.1200/Jco.2010.28.15_Suppl.E13613 |
0.309 |
|
| 2010 |
Sethi S, Sarkar FH, Ahmed Q, Bandyopadhyay S, Nahleh ZA, Sakr W, Munkarah A, Ali-Fehmi R. Molecular markers for epithelial-mesenchymal transition (EMT) and tumor aggressiveness in breast carcinoma. Journal of Clinical Oncology. 28: 10604-10604. DOI: 10.1200/Jco.2010.28.15_Suppl.10604 |
0.316 |
|
| 2010 |
Jaiswal AS, Banerjee S, Panda H, Bulkin CD, Izumi T, Sarkar FH, Ostrov DA, Narayan S. Abstract 692: Antitumor activity of novel structure-based chemotherapeutic agent for the intervention of colorectal cancer Cancer Research. 70: 692-692. DOI: 10.1158/1538-7445.Am10-692 |
0.447 |
|
| 2010 |
Singh-Gupta V, Zhang H, Yunker C, Sarkar F, Hillman GG. Abstract 5541: Daidzein protects against genistein-induced lymph node metastasis, and serve as a radiosensitizer in prostate cancer Cancer Research. 70: 5541-5541. DOI: 10.1158/1538-7445.Am10-5541 |
0.426 |
|
| 2010 |
Ali S, Banerjee S, Schaffert JM, El-Rayes BF, Philip PA, Sarkar FH. Abstract 5420: Multi-targeted approach for inhibiting pancreatic tumor growthin vivoconsistent within vitroresults Cancer Research. 70: 5420-5420. DOI: 10.1158/1538-7445.Am10-5420 |
0.316 |
|
| 2010 |
Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Sarkar FH, Rishi AK, Mohammad R, Patel BB, Majumdar A. Abstract 5406: ErbB inhibitory protein [EBIP], a modified ectodomain of EGFR, synergizes with dasatinib to inhibit growth of breast cancer cells Cancer Research. 70: 5406-5406. DOI: 10.1158/1538-7445.Am10-5406 |
0.476 |
|
| 2010 |
Azmi AS, Philip PA, Aboukameel A, Banerjee S, Wang Z, Wang S, Yang D, Sarkar FH, Mohammad RM. Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function Cancer Research. 70: 4535-4535. DOI: 10.1158/1538-7445.Am10-4535 |
0.527 |
|
| 2010 |
Ahmad A, Kong D, Wang Z, Ali R, Banerjee S, Sarkar FH. Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways Cancer Research. 70: 3118-3118. DOI: 10.1158/1538-7445.Am10-3118 |
0.52 |
|
| 2010 |
Banerjee S, Wang Z, Azmi A, Kong D, Ahmad A, Sarkar FH. Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model Cancer Research. 70: 2561-2561. DOI: 10.1158/1538-7445.Am10-2561 |
0.588 |
|
| 2010 |
Azmi AS, Sarkar FH, Mohammad RM. Abstract A36: Systems biology: Implications in assessing drug-drug interactions in pancreatic cancer Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-A36 |
0.43 |
|
| 2010 |
Nautiyal J, Banerjee S, Kanwar SS, Sarkar F, Majumdar AP. T1170 Curcumin Synergizes With C-SRC Inhibitor Dasatinib in Inhibiting Colon Cancer Gastroenterology. 138: S-503-S-504. DOI: 10.1016/S0016-5085(10)62325-6 |
0.379 |
|
| 2010 |
Devpura S, Thakur JS, Sarkar FH, Sakr WA, Naik VM, Naik R. Detection of benign epithelia, prostatic intraepithelial neoplasia, and cancer regions in radical prostatectomy tissues using Raman spectroscopy Vibrational Spectroscopy. 53: 227-232. DOI: 10.1016/J.Vibspec.2010.03.009 |
0.33 |
|
| 2009 |
Adsule S, Banerjee S, Ahmed F, Padhye S, Sarkar FH. Hybrid anticancer agents: isothiocyanate-progesterone conjugates as chemotherapeutic agents and insights into their cytotoxicities. Bioorganic & Medicinal Chemistry Letters. 20: 1247-51. PMID 20022750 DOI: 10.1016/J.Bmcl.2009.11.128 |
0.416 |
|
| 2009 |
Ahmad A, Banerjee S, Wang Z, Kong D, Majumdar AP, Sarkar FH. Aging and inflammation: etiological culprits of cancer. Current Aging Science. 2: 174-86. PMID 19997527 DOI: 10.2174/1874609810902030174 |
0.471 |
|
| 2009 |
Jaiswal AS, Banerjee S, Panda H, Bulkin CD, Izumi T, Sarkar FH, Ostrov DA, Narayan S. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells. Molecular Cancer Research : McR. 7: 1973-83. PMID 19996303 DOI: 10.1158/1541-7786.Mcr-09-0309 |
0.376 |
|
| 2009 |
Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Translational Oncology. 2: 321-8. PMID 19956394 DOI: 10.1593/Tlo.09193 |
0.464 |
|
| 2009 |
Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E, Sarkar FH. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutrition and Cancer. 61: 544-53. PMID 19838927 DOI: 10.1080/01635580902752262 |
0.527 |
|
| 2009 |
Padhye S, Ahmad A, Oswal N, Sarkar FH. Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. Journal of Hematology & Oncology. 2: 38. PMID 19725977 DOI: 10.1186/1756-8722-2-38 |
0.373 |
|
| 2009 |
Sarkar FH, Li Y. Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treatment Reviews. 35: 597-607. PMID 19660870 DOI: 10.1016/J.Ctrv.2009.07.001 |
0.46 |
|
| 2009 |
Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Research. 69: 6704-12. PMID 19654291 DOI: 10.1158/0008-5472.Can-09-1298 |
0.539 |
|
| 2009 |
Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM. Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Research. 69: 6083-91. PMID 19622773 DOI: 10.1158/0008-5472.Can-08-3309 |
0.418 |
|
| 2009 |
Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, Sarkar FH, Mohammad RM. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Research. 69: 5575-83. PMID 19549912 DOI: 10.1158/0008-5472.Can-08-4235 |
0.574 |
|
| 2009 |
Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells (Dayton, Ohio). 27: 1712-21. PMID 19544444 DOI: 10.1002/Stem.101 |
0.509 |
|
| 2009 |
Banerjee S, Wang Z, Kong D, Sarkar FH. 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Research. 69: 5592-600. PMID 19531648 DOI: 10.1158/0008-5472.Can-09-0838 |
0.592 |
|
| 2009 |
Padhye S, Yang H, Jamadar A, Cui QC, Chavan D, Dominiak K, McKinney J, Banerjee S, Dou QP, Sarkar FH. New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Pharmaceutical Research. 26: 1874-80. PMID 19421843 DOI: 10.1007/S11095-009-9900-8 |
0.444 |
|
| 2009 |
Giri B, Gomes A, Sengupta R, Banerjee S, Nautiyal J, Sarkar FH, Majumdar AP. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Anticancer Research. 29: 395-401. PMID 19331178 |
0.319 |
|
| 2009 |
Ahmad A, Kong D, Sarkar SH, Wang Z, Banerjee S, Sarkar FH. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration. Journal of Cellular Biochemistry. 107: 516-27. PMID 19330806 DOI: 10.1002/Jcb.22152 |
0.578 |
|
| 2009 |
Ali S, Al-Sukhun S, El-Rayes BF, Sarkar FH, Heilbrun LK, Philip PA. Protein kinases C isozymes are differentially expressed in human breast carcinomas. Life Sciences. 84: 766-71. PMID 19324060 DOI: 10.1016/J.Lfs.2009.03.007 |
0.325 |
|
| 2009 |
Wang Z, Azmi AS, Ahmad A, Banerjee S, Wang S, Sarkar FH, Mohammad RM. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway. Cancer Research. 69: 2757-65. PMID 19318573 DOI: 10.1158/0008-5472.Can-08-3060 |
0.594 |
|
| 2009 |
Sarkar FH, Li Y, Wang Z, Kong D. Cellular signaling perturbation by natural products. Cellular Signalling. 21: 1541-7. PMID 19298854 DOI: 10.1016/J.Cellsig.2009.03.009 |
0.59 |
|
| 2009 |
Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer. 115: 2165-76. PMID 19288574 DOI: 10.1002/Cncr.24250 |
0.394 |
|
| 2009 |
Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, Ali S, Abbruzzese JL, Gallick GE, Sarkar FH. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Research. 69: 2400-7. PMID 19276344 DOI: 10.1158/0008-5472.Can-08-4312 |
0.579 |
|
| 2009 |
Ali S, Varghese L, Pereira L, Tulunay-Ugur OE, Kucuk O, Carey TE, Wolf GT, Sarkar FH. Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents. Cancer Letters. 278: 201-9. PMID 19231069 DOI: 10.1016/J.Canlet.2009.01.009 |
0.375 |
|
| 2009 |
Patel BB, Yu Y, Du J, Rishi AK, Sarkar FH, Tarca AL, Wali A, Majumdar AP. Schlafen 3, a novel gene, regulates colonic mucosal growth during aging. American Journal of Physiology. Gastrointestinal and Liver Physiology. 296: G955-62. PMID 19228883 DOI: 10.1152/Ajpgi.90726.2008 |
0.338 |
|
| 2009 |
Wang Z, Kong D, Li Y, Sarkar FH. PDGF-D signaling: a novel target in cancer therapy. Current Drug Targets. 10: 38-41. PMID 19149534 DOI: 10.2174/138945009787122914 |
0.524 |
|
| 2009 |
Singh-Gupta V, Zhang H, Banerjee S, Kong D, Raffoul JJ, Sarkar FH, Hillman GG. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. International Journal of Cancer. 124: 1675-84. PMID 19101986 DOI: 10.1002/Ijc.24015 |
0.369 |
|
| 2009 |
Chinnakannu K, Chen D, Li Y, Wang Z, Dou QP, Reddy GP, Sarkar FH. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells. Journal of Cellular Physiology. 219: 94-9. PMID 19062173 DOI: 10.1002/Jcp.21650 |
0.578 |
|
| 2009 |
Wang Z, Li Y, Banerjee S, Sarkar FH. Emerging role of Notch in stem cells and cancer. Cancer Letters. 279: 8-12. PMID 19022563 DOI: 10.1016/J.Canlet.2008.09.030 |
0.559 |
|
| 2009 |
Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. Journal of Cellular Biochemistry. 105: 1461-71. PMID 18980240 DOI: 10.1002/Jcb.21966 |
0.566 |
|
| 2008 |
Hammad N, Philip PA, Shields AF, Sarkar FH, Abruzzese JL, Kaseb AO, Javle MM, Varadhachary GR, Wolff RA, El-Rayes BF. A phase II study of isoflavone, gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 15540. PMID 27947415 DOI: 10.1200/Jco.2008.26.15_Suppl.15540 |
0.442 |
|
| 2008 |
Kaseb AO, Banerjee S, Wang Z, Sarkar FH, Ramzi M. Enhanced chemosensitivity to gemcitabine and oxaliplatin by thymoquinone in pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 15565. PMID 27947380 DOI: 10.1200/Jco.2008.26.15_Suppl.15565 |
0.571 |
|
| 2008 |
Vandenboom Ii TG, Li Y, Philip PA, Sarkar FH. MicroRNA and Cancer: Tiny Molecules with Major Implications. Current Genomics. 9: 97-109. PMID 19440450 DOI: 10.2174/138920208784139555 |
0.339 |
|
| 2008 |
Wang Z, Li Y, Banerjee S, Sarkar FH. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Research. 28: 3621-30. PMID 19189643 |
0.421 |
|
| 2008 |
Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, Tan W, Ivy SP, Pili R, Carducci MA, Erlichman C, Liu G. A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7940-6. PMID 19047126 DOI: 10.1158/1078-0432.Ccr-08-0221 |
0.385 |
|
| 2008 |
Solomon LA, Ali S, Banerjee S, Munkarah AR, Morris RT, Sarkar FH. Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. Journal of Ovarian Research. 1: 9. PMID 19025644 DOI: 10.1186/1757-2215-1-9 |
0.477 |
|
| 2008 |
Sarkar FH, Li Y, Wang Z, Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. International Reviews of Immunology. 27: 293-319. PMID 18853341 DOI: 10.1080/08830180802276179 |
0.516 |
|
| 2008 |
Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Research. 68: 7283-92. PMID 18794115 DOI: 10.1158/0008-5472.Can-07-6246 |
0.51 |
|
| 2008 |
Azmi AS, Wang Z, Burikhanov R, Rangnekar VM, Wang G, Chen J, Wang S, Sarkar FH, Mohammad RM. Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis. Molecular Cancer Therapeutics. 7: 2884-93. PMID 18790769 DOI: 10.1158/1535-7163.Mct-08-0438 |
0.579 |
|
| 2008 |
Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH. Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treatment Reviews. 35: 1-8. PMID 18778896 DOI: 10.1016/J.Ctrv.2008.07.006 |
0.416 |
|
| 2008 |
Yang H, Murthy S, Sarkar FH, Sheng S, Reddy GP, Dou QP. Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. Journal of Cellular Physiology. 217: 569-76. PMID 18726991 DOI: 10.1002/Jcp.21565 |
0.458 |
|
| 2008 |
Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. The Journal of Biological Chemistry. 283: 27707-16. PMID 18687691 DOI: 10.1074/Jbc.M802759200 |
0.522 |
|
| 2008 |
Wang Z, Desmoulin S, Banerjee S, Kong D, Li Y, Deraniyagala RL, Abbruzzese J, Sarkar FH. Synergistic effects of multiple natural products in pancreatic cancer cells. Life Sciences. 83: 293-300. PMID 18640131 DOI: 10.1016/J.Lfs.2008.06.017 |
0.559 |
|
| 2008 |
Thakur A, Sun Y, Bollig A, Wu J, Biliran H, Banerjee S, Sarkar FH, Liao DJ. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4427-36. PMID 18628456 DOI: 10.1158/1078-0432.Ccr-08-0458 |
0.401 |
|
| 2008 |
Ali S, Banerjee S, Ahmad A, El-Rayes BF, Philip PA, Sarkar FH. Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Molecular Cancer Therapeutics. 7: 1708-19. PMID 18566242 DOI: 10.1158/1535-7163.Mct-08-0354 |
0.414 |
|
| 2008 |
Wang Z, Song W, Aboukameel A, Mohammad M, Wang G, Banerjee S, Kong D, Wang S, Sarkar FH, Mohammad RM. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. International Journal of Cancer. Journal International Du Cancer. 123: 958-66. PMID 18528859 DOI: 10.1002/Ijc.23610 |
0.626 |
|
| 2008 |
Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Letters. 269: 226-42. PMID 18492603 DOI: 10.1016/J.Canlet.2008.03.052 |
0.633 |
|
| 2008 |
El-Rayes BF, Ali S, Philip PA, Sarkar FH. Protein kinase C: a target for therapy in pancreatic cancer. Pancreas. 36: 346-52. PMID 18437080 DOI: 10.1097/Mpa.0B013E31815Ceaf7 |
0.452 |
|
| 2008 |
Azmi AS, Ahmad A, Banerjee S, Rangnekar VM, Mohammad RM, Sarkar FH. Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM). Pharmaceutical Research. 25: 2117-24. PMID 18427961 DOI: 10.1007/S11095-008-9581-8 |
0.5 |
|
| 2008 |
Kong D, Wang Z, Sarkar SH, Li Y, Banerjee S, Saliganan A, Kim HR, Cher ML, Sarkar FH. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells (Dayton, Ohio). 26: 1425-35. PMID 18403754 DOI: 10.1634/Stemcells.2007-1076 |
0.583 |
|
| 2008 |
Pandya AK, Serhatkulu GK, Cao A, Kast RE, Dai H, Rabah R, Poulik J, Banerjee S, Naik R, Adsay V, Auner GW, Klein MD, Thakur JS, Sarkar FH. Evaluation of pancreatic cancer with Raman spectroscopy in a mouse model. Pancreas. 36: e1-8. PMID 18376295 DOI: 10.1097/Mpa.0B013E31815A3F1C |
0.325 |
|
| 2008 |
Kong D, Banerjee S, Huang W, Li Y, Wang Z, Kim HR, Sarkar FH. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Cancer Research. 68: 1927-34. PMID 18339874 DOI: 10.1158/0008-5472.Can-07-3241 |
0.521 |
|
| 2008 |
Banerjee S, Wang Z, Mohammad M, Sarkar FH, Mohammad RM. Efficacy of selected natural products as therapeutic agents against cancer. Journal of Natural Products. 71: 492-6. PMID 18302335 DOI: 10.1021/Np0705716 |
0.442 |
|
| 2008 |
Wang Z, Yu BW, Rahman KM, Ahmad F, Sarkar FH. Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip. Molecular Cancer Therapeutics. 7: 341-9. PMID 18281517 DOI: 10.1158/1535-7163.Mct-07-0476 |
0.566 |
|
| 2008 |
Friedman J, Dunn RL, Wood D, Vaishampayan U, Wu A, Bradley D, Montie J, Sarkar FH, Shah RB, Hussain M. Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer Journal of Urology. 179: 911-916. PMID 18207190 DOI: 10.1016/J.Juro.2007.10.064 |
0.347 |
|
| 2008 |
Liao DJ, Thakur A, Wu J, Biliran H, Sarkar FH. Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Critical Reviews in Oncogenesis. 13: 93-158. PMID 18197790 DOI: 10.1615/Critrevoncog.V13.I2.10 |
0.423 |
|
| 2008 |
Wang Z, Kong D, Banerjee S, Li Y, Adsay NV, Abbruzzese J, Sarkar FH. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Research. 67: 11377-85. PMID 18056465 DOI: 10.1158/0008-5472.Can-07-2803 |
0.476 |
|
| 2008 |
Sarkar FH, Li Y. NF-kappaB: a potential target for cancer chemoprevention and therapy. Frontiers in Bioscience : a Journal and Virtual Library. 13: 2950-9. PMID 17981768 DOI: 10.2741/2900 |
0.516 |
|
| 2008 |
Gadgeel SM, Ali S, Philip PA, Ahmed F, Wozniak A, Sarkar FH. Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor. Cancer. 110: 2775-84. PMID 17948911 DOI: 10.1002/Cncr.23100 |
0.341 |
|
| 2008 |
Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes JE, Kucuk O. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutrition and Cancer. 59: 1-7. PMID 17927495 DOI: 10.1080/01635580701413934 |
0.388 |
|
| 2008 |
Wang Z, Azmi AS, Banerjee S, Aboukameel A, Wang S, Sarkar FH, Mohammad RM. TW-37 INHIBITS CELL GROWTH AND INDUCES APOPTOSIS IN PANCREATIC CANCER Pancreas. 37: 500. DOI: 10.1097/01.Mpa.0000335408.77670.4A |
0.577 |
|
| 2008 |
Banerjee S, Kaseb A, Wang Z, Kong D, Padhaye S, Mohammad R, Sarkar FH. IN VIVO MOLECULAR EVIDENCE FOR ENHANCED CHEMOSENSITIVITY OF PANCREATIC CANCER CELLS TO GEMCITABINE AND OXALIPLATIN BY THYMOQUINONE Pancreas. 37: 461. DOI: 10.1097/01.Mpa.0000335341.28085.C8 |
0.569 |
|
| 2008 |
Ahmad IU, Forman JD, Sarkar F, Hillman G, Banerjee M, Doerge D, Heath E, Vaishampayan U, Cher M, Kucuk O. Reduction of Adverse Events by Soy Isoflavones in Patients Undergoing External Beam Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1096 |
0.33 |
|
| 2007 |
Raffoul JJ, Sarkar FH, Hillman GG. Radiosensitization of prostate cancer by soy isoflavones. Current Cancer Drug Targets. 7: 759-65. PMID 18220535 DOI: 10.2174/156800907783220408 |
0.543 |
|
| 2007 |
Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. Evolving role of uPA/uPAR system in human cancers. Cancer Treatment Reviews. 34: 122-36. PMID 18162327 DOI: 10.1016/J.Ctrv.2007.10.005 |
0.503 |
|
| 2007 |
Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Research. 67: 8293-300. PMID 17804744 DOI: 10.1158/0008-5472.Can-07-1265 |
0.58 |
|
| 2007 |
Sarkar FH, Li YW. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacologica Sinica. 28: 1305-15. PMID 17723164 DOI: 10.1111/J.1745-7254.2007.00689.X |
0.479 |
|
| 2007 |
Ambike V, Adsule S, Ahmed F, Wang Z, Afrasiabi Z, Sinn E, Sarkar F, Padhye S. Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells. Journal of Inorganic Biochemistry. 101: 1517-24. PMID 17689613 DOI: 10.1016/J.Jinorgbio.2007.06.028 |
0.502 |
|
| 2007 |
Sarkar FH, Adsule S, Li Y, Padhye S. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Reviews in Medicinal Chemistry. 7: 599-608. PMID 17584158 DOI: 10.2174/138955707780859431 |
0.518 |
|
| 2007 |
Schmelz EM, Xu H, Sengupta R, Du J, Banerjee S, Sarkar FH, Rishi AK, Majumdar AP. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein. Cancer Research. 67: 5389-96. PMID 17545620 DOI: 10.1158/0008-5472.Can-07-0536 |
0.396 |
|
| 2007 |
Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. The Journal of Biological Chemistry. 282: 21542-50. PMID 17522055 DOI: 10.1074/Jbc.M701978200 |
0.518 |
|
| 2007 |
Biliran H, Banerjee S, Thakur A, Sarkar FH, Bollig A, Ahmed F, Wu J, Sun Y, Liao JD. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2811-21. PMID 17473215 DOI: 10.1158/1078-0432.Ccr-06-1844 |
0.466 |
|
| 2007 |
Li X, Chen D, Yin S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP, Sheng S. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. Journal of Cellular Physiology. 212: 298-306. PMID 17458898 DOI: 10.1002/Jcp.21102 |
0.494 |
|
| 2007 |
Banerjee S, Hussain M, Wang Z, Saliganan A, Che M, Bonfil D, Cher M, Sarkar FH. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. Cancer Research. 67: 3818-26. PMID 17440096 DOI: 10.1158/0008-5472.Can-06-3879 |
0.563 |
|
| 2007 |
Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Research. 67: 3310-9. PMID 17409440 DOI: 10.1158/0008-5472.Can-06-4277 |
0.453 |
|
| 2007 |
Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Research. 67: 2141-9. PMID 17332344 DOI: 10.1158/0008-5472.Can-06-2147 |
0.426 |
|
| 2007 |
Thakur A, Rahman KW, Wu J, Bollig A, Biliran H, Lin X, Nassar H, Grignon DJ, Sarkar FH, Liao JD. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer. Molecular Cancer Research : McR. 5: 171-81. PMID 17314274 DOI: 10.1158/1541-7786.Mcr-06-0071 |
0.39 |
|
| 2007 |
Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Research. 67: 1636-44. PMID 17308104 DOI: 10.1158/0008-5472.Can-06-3546 |
0.509 |
|
| 2007 |
Raffoul JJ, Banerjee S, Che M, Knoll ZE, Doerge DR, Abrams J, Kucuk O, Sarkar FH, Hillman GG. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. International Journal of Cancer. 120: 2491-8. PMID 17304503 DOI: 10.1002/Ijc.22548 |
0.436 |
|
| 2007 |
Hillman GG, Wang Y, Che M, Raffoul JJ, Yudelev M, Kucuk O, Sarkar FH. Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. Bmc Cancer. 7: 4. PMID 17212824 DOI: 10.1186/1471-2407-7-4 |
0.368 |
|
| 2007 |
Ahmed F, Adsule S, Ali AS, Banerjee S, Ali S, Kulkarni S, Padhye S, Sarkar FH. A novel copper complex of 3-benzoyl-alpha methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway. International Journal of Cancer. 120: 734-42. PMID 17131340 DOI: 10.1002/Ijc.22383 |
0.428 |
|
| 2007 |
Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL, Sarkar FH. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. International Journal of Cancer. 120: 906-17. PMID 17131310 DOI: 10.1002/Ijc.22332 |
0.608 |
|
| 2007 |
Adsule S, Barve V, Chen D, Ahmed F, Dou QP, Padhye S, Sarkar FH. Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells. Journal of Medicinal Chemistry. 49: 7242-6. PMID 17125278 DOI: 10.1021/Jm060712L |
0.43 |
|
| 2007 |
Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, Sarkar NH. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Molecular Cancer Therapeutics. 5: 2747-56. PMID 17121921 DOI: 10.1158/1535-7163.Mct-06-0221 |
0.521 |
|
| 2007 |
Friedman JD, Vaishampayan U, Wood D, Wu A, Bradley D, Dunn RL, Montie J, Sarkar FH, Shah R, Hussain M. Neoadjuvant docetaxel and capecitabine in patients (Pts) with high-risk prostate cancer (PCa): Final results of a phase II trial Journal of Clinical Oncology. 25: 5147-5147. DOI: 10.1200/Jco.2007.25.18_Suppl.5147 |
0.351 |
|
| 2007 |
Heath EI, Hillman D, Vaishampayan U, Sheng S, Sarkar FH, Gaskins M, Pitot HC, Tan W, Ivy P, Pili R. A phase II trial of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in patients with hormone-refractory metastatic prostate cancer Journal of Clinical Oncology. 25: 15553-15553. DOI: 10.1200/Jco.2007.25.18_Suppl.15553 |
0.339 |
|
| 2007 |
Wang Z, Song W, Aboukameel A, Wang G, Wang S, Sarkar FH, Mohammad RM. TW-37, A NONPEPTIDIC SMALL-MOLECULE INHIBITOR OF BCL-2, INHIBITS INVASION AND ANGIOGENESIS IN PANCREATIC CANCER Pancreas. 35: 434-435. DOI: 10.1097/01.Mpa.0000297810.50526.D6 |
0.524 |
|
| 2007 |
Wang Z, Kong D, Banerjee S, Li Y, Sarkar FH. DOWN-REGULATION OF PDGF-D INHIBITS CELL GROWTH AND ANGIOGENESIS THROUGH INACTIVATION OF NOTCH-1 AND NF-κB SIGNALING Pancreas. 35: 434. DOI: 10.1097/01.Mpa.0000297809.34035.22 |
0.383 |
|
| 2007 |
Sarkar F, Banerjee S, Wang Z, Li Y, Abbruzzese J. A NOVEL NON-TOXIC MULTI-TARGETED APPROACH FOR PANCREATIC CANCER THERAPY Pancreas. 35: 425. DOI: 10.1097/01.Mpa.0000297777.10272.13 |
0.49 |
|
| 2007 |
Banerjee S, Wang Z, Kong D, Sarkar FH. IN VIVO MOLECULAR EVIDENCE OF CHEMOSENSITIZATION BY 3,3-DIINDOLYLMETHANE AGAINST PANCREATIC TUMOR Pancreas. 35: 393. DOI: 10.1097/01.Mpa.0000297666.91040.B8 |
0.337 |
|
| 2007 |
Schmelz EM, Xu H, Du J, Sarkar FH, Rishi A, Majumdar AP. TREATMENT OF EARLY AND INTERMEDIATE STAGES OF COLORECTAL CANCER WITH EGF‐RECEPTOR RELATED PROTEIN (ERRP). The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A31 |
0.34 |
|
| 2007 |
Shingnapurkar D, Butcher R, Afrasiabi Z, Sinn E, Ahmed F, Sarkar F, Padhye S. Neutral dimeric copper–sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line Inorganic Chemistry Communications. 10: 459-462. DOI: 10.1016/J.Inoche.2006.12.016 |
0.428 |
|
| 2006 |
Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH. The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. International Journal of Gastrointestinal Cancer. 37: 139-45. PMID 18049799 DOI: 10.1007/S12029-007-9005-8 |
0.393 |
|
| 2006 |
Sarkar FH, Banerjee S, Li Y. Pancreatic cancer: pathogenesis, prevention and treatment. Toxicology and Applied Pharmacology. 224: 326-36. PMID 17174370 DOI: 10.1016/J.Taap.2006.11.007 |
0.483 |
|
| 2006 |
El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Research. 66: 10553-9. PMID 17079479 DOI: 10.1158/0008-5472.Can-06-2333 |
0.483 |
|
| 2006 |
Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Research. 66: 10064-72. PMID 17047070 DOI: 10.1158/0008-5472.Can-06-2011 |
0.554 |
|
| 2006 |
Reddy S, Rishi AK, Xu H, Levi E, Sarkar FH, Majumdar AP. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells. Nutrition and Cancer. 55: 185-94. PMID 17044774 DOI: 10.1207/S15327914Nc5502_10 |
0.467 |
|
| 2006 |
Beck FW, Li Y, Bao B, Prasad AS, Sarkar FH. Evidence for reprogramming global gene expression during zinc deficiency in the HUT-78 cell line. Nutrition (Burbank, Los Angeles County, Calif.). 22: 1045-56. PMID 16979875 DOI: 10.1016/J.Nut.2006.08.001 |
0.37 |
|
| 2006 |
Wang Z, Sengupta R, Banerjee S, Li Y, Zhang Y, Rahman KM, Aboukameel A, Mohammad R, Majumdar AP, Abbruzzese JL, Sarkar FH. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. Cancer Research. 66: 7653-60. PMID 16885366 DOI: 10.1158/0008-5472.Can-06-1019 |
0.605 |
|
| 2006 |
Zhang Y, Wang Z, Ahmed F, Banerjee S, Li Y, Sarkar FH. Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells. International Journal of Cancer. 119: 2071-7. PMID 16823852 DOI: 10.1002/Ijc.22077 |
0.572 |
|
| 2006 |
Liao DJ, Wang Y, Wu J, Adsay NV, Grignon D, Khanani F, Sarkar FH. Characterization of pancreatic lesions from MT-tgf alpha, Ela-myc and MT-tgf alpha/Ela-myc single and double transgenic mice. Journal of Carcinogenesis. 5: 19. PMID 16822304 DOI: 10.1186/1477-3163-5-19 |
0.318 |
|
| 2006 |
Wang Y, Raffoul JJ, Che M, Doerge DR, Joiner MC, Kucuk O, Sarkar FH, Hillman GG. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model. Radiation Research. 166: 73-80. PMID 16808622 DOI: 10.1667/Rr3590.1 |
0.385 |
|
| 2006 |
Barve V, Ahmed F, Adsule S, Banerjee S, Kulkarni S, Katiyar P, Anson CE, Powell AK, Padhye S, Sarkar FH. Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. Journal of Medicinal Chemistry. 49: 3800-8. PMID 16789737 DOI: 10.1021/Jm051068Y |
0.387 |
|
| 2006 |
Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Research. 66: 4952-60. PMID 16651453 DOI: 10.1158/0008-5472.Can-05-3918 |
0.606 |
|
| 2006 |
Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, Sarkar FH. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Research. 66: 4816-25. PMID 16651437 DOI: 10.1158/0008-5472.Can-05-3752 |
0.455 |
|
| 2006 |
Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. Bmc Cancer. 6: 107. PMID 16640785 DOI: 10.1186/1471-2407-6-107 |
0.476 |
|
| 2006 |
Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 106: 2503-13. PMID 16628653 DOI: 10.1002/Cncr.21904 |
0.605 |
|
| 2006 |
Shen XJ, Ali-Fehmi R, Weng CR, Sarkar FH, Grignon D, Liao DJ. Loss of heterozygosity and microsatellite instability at the Xq28 and the A/G heterozygosity of the QM gene are associated with ovarian cancer. Cancer Biology & Therapy. 5: 523-8. PMID 16627977 DOI: 10.4161/Cbt.5.5.2610 |
0.327 |
|
| 2006 |
Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer. Journal of Cellular Biochemistry. 98: 1408-23. PMID 16619263 DOI: 10.1002/Jcb.20927 |
0.415 |
|
| 2006 |
Sarkar FH, Adsule S, Padhye S, Kulkarni S, Li Y. The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini Reviews in Medicinal Chemistry. 6: 401-7. PMID 16613577 DOI: 10.2174/138955706776361439 |
0.553 |
|
| 2006 |
Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Research. 66: 3347-50. PMID 16585150 DOI: 10.1158/0008-5472.Can-05-4526 |
0.492 |
|
| 2006 |
Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics. 5: 483-93. PMID 16546962 DOI: 10.1158/1535-7163.Mct-05-0299 |
0.622 |
|
| 2006 |
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Research. 66: 2778-84. PMID 16510599 DOI: 10.1158/0008-5472.Can-05-4281 |
0.498 |
|
| 2006 |
Sarkar FH, Li Y. Markers of apoptosis. Methods in Molecular Medicine. 120: 147-60. PMID 16491600 DOI: 10.1385/1-59259-969-9:147 |
0.494 |
|
| 2006 |
Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer. 106: 1260-8. PMID 16475211 DOI: 10.1002/Cncr.21731 |
0.41 |
|
| 2006 |
Davis DA, Sarkar SH, Hussain M, Li Y, Sarkar FH. Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line. Bmc Cancer. 6: 22. PMID 16433906 DOI: 10.1186/1471-2407-6-22 |
0.404 |
|
| 2006 |
Zhang Y, Banerjee S, Wang Z, Xu H, Zhang L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, Majumdar AP, Sarkar FH. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Research. 66: 1025-32. PMID 16424038 DOI: 10.1158/0008-5472.Can-05-2968 |
0.557 |
|
| 2006 |
Ali S, El-Rayes BF, Sarkar FH, Philip PA. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy. Molecular Cancer Therapeutics. 4: 1943-51. PMID 16373709 DOI: 10.1158/1535-7163.Mct-05-0065 |
0.435 |
|
| 2006 |
Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. International Journal of Cancer. 118: 1930-6. PMID 16284950 DOI: 10.1002/Ijc.21589 |
0.615 |
|
| 2006 |
Gadgeel SM, Ali S, Philip P, Wozniak A, Sarkar F. Dual blockade of epidermal growth factor receptor (EGFR) and cyclooxygenase 2 (COX 2) may be dependent upon the EGFR mutational status in non-small cell lung cancer (NSCLC) cell lines Journal of Clinical Oncology. 24: 7170-7170. DOI: 10.1200/Jco.2006.24.18_Suppl.7170 |
0.349 |
|
| 2006 |
Thoutreddy S, Ali S, Mohammad R, Sarkar FH. Sensitization of pancreatic cancer cells to ApoG2 induced killing by curcumin Journal of Clinical Oncology. 24: 13152-13152. DOI: 10.1200/Jco.2006.24.18_Suppl.13152 |
0.462 |
|
| 2006 |
Thoutreddy S, Mohammad RM, Ali S, Wang S, Sarkar FH. CURCUMIN SENSITIZES PANCREATIC CANCER CELLS TO APOG2 INDUCED KILLING Pancreas. 33: 502. DOI: 10.1097/00006676-200611000-00219 |
0.485 |
|
| 2006 |
Banerjee S, Wang Z, Chaio PJ, Sarkar FH. MOLECULAR EVIDENCE OF 3,3???-DIINDOLYLMETHANE INDUCED ENHANCEMENT IN CHEMOSENSITIVITY OF PANCREATIC CANCER CELLS TO MULTIPLE CHEMOTHERAPEUTIC AGENTS Pancreas. 33: 445. DOI: 10.1097/00006676-200611000-00035 |
0.501 |
|
| 2006 |
Hillman G, Raffoul J, Wang Y, Kucuk O, Joiner M, Yudelev M, Forman J, Che M, Sarkar F. 146 Radiosensitization of prostate cancer by genistein in vitro and in an orthotopic model in vivo Radiotherapy and Oncology. 78: S48-S49. DOI: 10.1016/S0167-8140(06)80625-0 |
0.395 |
|
| 2005 |
Friedman JD, Vaishampayan U, Montie J, Shah R, Sarkar F, Smith D, Hussain M. Neoadjuvant docetaxel and capecitabine in patients with high risk/locally advanced prostate cancer: Preliminary results of a phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4742. PMID 27943952 DOI: 10.1200/Jco.2005.23.16_Suppl.4742 |
0.396 |
|
| 2005 |
Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, Sarkar FH. Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas. 31: 317-24. PMID 16258364 DOI: 10.1097/01.Mpa.0000179731.46210.01 |
0.439 |
|
| 2005 |
Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Research. 65: 9064-72. PMID 16204081 DOI: 10.1158/0008-5472.Can-05-1330 |
0.609 |
|
| 2005 |
Heath EI, Gaskins M, Pitot HC, Pili R, Tan W, Marschke R, Liu G, Hillman D, Sarkar F, Sheng S, Erlichman C, Ivy P. A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clinical Prostate Cancer. 4: 138-41. PMID 16197617 DOI: 10.3816/Cgc.2005.N.024 |
0.349 |
|
| 2005 |
Biliran H, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6075-86. PMID 16115953 DOI: 10.1158/1078-0432.Ccr-04-2419 |
0.471 |
|
| 2005 |
Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Research. 65: 6934-42. PMID 16061678 DOI: 10.1158/0008-5472.Can-04-4604 |
0.523 |
|
| 2005 |
Basturk O, Khanani F, Sarkar F, Levi E, Cheng JD, Adsay NV. DeltaNp63 expression in pancreas and pancreatic neoplasia. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 18: 1193-8. PMID 15976814 DOI: 10.1038/Modpathol.3800401 |
0.349 |
|
| 2005 |
Bollig A, Du QQ, Fan ST, Yu B, Sarkar FH, Liao J. Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cells. Oncology Reports. 14: 177-83. PMID 15944786 |
0.313 |
|
| 2005 |
Zhang Y, Banerjee S, Wang ZW, Marciniak DJ, Majumdar AP, Sarkar FH. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Cancer Research. 65: 3877-82. PMID 15867387 DOI: 10.1158/0008-5472.Can-04-3654 |
0.564 |
|
| 2005 |
Gupta SV, McGowen RM, Callewaert DM, Brown TR, Li Y, Sarkar FH. Quantitative chemiluminescent immunoassay for NF-kappaB-DNA binding activity. Journal of Immunoassay & Immunochemistry. 26: 125-43. PMID 15794122 DOI: 10.1081/Ias-200051996 |
0.317 |
|
| 2005 |
Ali S, El-Rayes BF, Aranha O, Sarkar FH, Philip PA. Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells. Breast Cancer Research and Treatment. 90: 25-31. PMID 15770523 DOI: 10.1007/S10549-004-2179-X |
0.774 |
|
| 2005 |
Xu H, Yu Y, Marciniak D, Rishi AK, Sarkar FH, Kucuk O, Majumdar AP. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Molecular Cancer Therapeutics. 4: 435-42. PMID 15767552 DOI: 10.1158/1535-7163.Mct-04-0280 |
0.452 |
|
| 2005 |
Li Y, Hong X, Hussain M, Sarkar SH, Li R, Sarkar FH. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Molecular Cancer Therapeutics. 4: 389-98. PMID 15767548 DOI: 10.1158/1535-7163.Mct-04-0244 |
0.476 |
|
| 2005 |
Rahman KW, Sarkar FH. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Research. 65: 364-71. PMID 15665315 |
0.378 |
|
| 2005 |
Li Y, Hussain M, Sarkar SH, Eliason J, Li R, Sarkar FH. Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells. Bmc Cancer. 5: 7. PMID 15656911 DOI: 10.1186/1471-2407-5-7 |
0.481 |
|
| 2005 |
Li Y, Chinni SR, Sarkar FH. Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. Frontiers in Bioscience : a Journal and Virtual Library. 10: 236-43. PMID 15574364 DOI: 10.2741/1523 |
0.5 |
|
| 2005 |
Sarkar FH, Li Y. Indole-3-carbinol and prostate cancer. The Journal of Nutrition. 134: 3493S-3498S. PMID 15570059 DOI: 10.1093/Jn/134.12.3493S |
0.484 |
|
| 2005 |
El-Rayes BF, Ali S, Sarkar FH, Philip PA. Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines. Molecular Cancer Therapeutics. 3: 1421-6. PMID 15542781 |
0.394 |
|
| 2005 |
Ali S, El-Rayes BF, Heilbrun LK, Sarkar FH, Ensley JF, Kucuk O, Philip PA. Cytochrome p450 and glutathione transferase expression in squamous cell cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4412-6. PMID 15240530 DOI: 10.1158/1078-0432.Ccr-04-0145 |
0.303 |
|
| 2005 |
Bollig A, Du QQ, Fan ST, Yu B, Sarkar FH, Liao J. Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cells. Oncology Reports. 14: 177-183. DOI: 10.3892/Or.14.1.177 |
0.426 |
|
| 2005 |
Wang Z, Zhang Y, Banerjee S, Sarkar FH. INHIBITION OF NUCLEAR FACTOR ??B ACTIVATION IN BXPC-3 CELLS BY GENISTEIN IS MEDIATED VIA NOTCH-1 SIGNALING PATHWAY Pancreas. 31: 478. DOI: 10.1097/01.Mpa.0000193794.36379.60 |
0.468 |
|
| 2005 |
Banerjee S, Zhang Y, Wang Z, Bhuiyan M, Chiao PJ, Sarkar FH. IN VIVO MOLECULAR EVIDENCE ON CHEMOSENSITIZATION OF PANCREATIC TUMOR BY GENISTEIN Pancreas. 31: 432-433. DOI: 10.1097/01.Mpa.0000193638.18935.8D |
0.429 |
|
| 2005 |
Adsule S, Barve V, Ambike V, Ahmed F, Banerjee S, Padhye SB, Sarkar FH. Synthesis And Biological Evaluation Of Novel Analogs Of Genistein And Selective Cox-2 Inhibitor And Their Metal Complexes In Pancreatic Cancer Pancreas. 31: 431. DOI: 10.1097/01.Mpa.0000183375.19542.F5 |
0.355 |
|
| 2005 |
Dutta S, Bendre R, Padhye S, Ahmed F, Sarkar F. Synthesis, Antioxidant Properties and Antiproliferative Activities of Tetrameric Copper and Copper‐Zinc Metal Complexes of Catecholamine Schiff Base Ligand Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry. 35: 3-10. DOI: 10.1081/Sim-200047494 |
0.408 |
|
| 2005 |
Dutta S, Padhye S, Ahmed F, Sarkar F. Pyridazolate-bridged dicopper (II) SOD mimics with enhanced antiproliferative activities against estrogen and androgen independent cancer cell lines Inorganica Chimica Acta. 358: 3617-3624. DOI: 10.1016/J.Ica.2005.05.032 |
0.41 |
|
| 2004 |
Ellis KL, Mohammad R, Wang S, Wu X, Chen J, Min J, Sarkar FH. Potentiation of apoptosis inducing activity of BL-193, an inhibitor of Bcl-XL protein, by genistein in pancreatic cancer cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3133. PMID 28014863 DOI: 10.1200/Jco.2004.22.14_Suppl.3133 |
0.471 |
|
| 2004 |
Marciniak DJ, Rishi AK, Sarkar FH, Majumdar AP. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells. Molecular Cancer Therapeutics. 3: 1615-21. PMID 15634655 |
0.338 |
|
| 2004 |
Levi E, Mohammad R, Kodali U, Marciniak D, Reddy S, Aboukameel A, Sarkar FH, Kucuk O, Rishi AK, Majumdar AP. EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo. Anticancer Research. 24: 2885-91. PMID 15517892 |
0.343 |
|
| 2004 |
Sarkar FH, Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutation Research. 555: 53-64. PMID 15476851 DOI: 10.1016/J.Mrfmmm.2004.04.015 |
0.53 |
|
| 2004 |
Sarkar FH, Li Y. The role of isoflavones in cancer chemoprevention. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2714-24. PMID 15353308 DOI: 10.2741/1430 |
0.497 |
|
| 2004 |
Li Y, Che M, Bhagat S, Ellis KL, Kucuk O, Doerge DR, Abrams J, Cher ML, Sarkar FH. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia (New York, N.Y.). 6: 354-63. PMID 15256057 DOI: 10.1593/Neo.03478 |
0.438 |
|
| 2004 |
Siddiq F, Sarkar FH, Wali A, Pass HI, Lonardo F. Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung. Lung Cancer (Amsterdam, Netherlands). 45: 197-205. PMID 15246191 DOI: 10.1016/J.Lungcan.2004.01.020 |
0.425 |
|
| 2004 |
Rahman KM, Li Y, Sarkar FH. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutrition and Cancer. 48: 84-94. PMID 15203382 DOI: 10.1207/S15327914Nc4801_12 |
0.475 |
|
| 2004 |
Hong X, Li Y, Hussain M, Sarkar FH. Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells. Cancer Letters. 209: 187-95. PMID 15159021 DOI: 10.1016/J.Canlet.2004.02.008 |
0.444 |
|
| 2004 |
Li Y, Li X, Hussain M, Sarkar FH. Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray. Neoplasia (New York, N.Y.). 6: 158-67. PMID 15140405 DOI: 10.1593/Neo.03391 |
0.477 |
|
| 2004 |
Li Y, Ellis KL, Ali S, El-Rayes BF, Nedeljkovic-Kurepa A, Kucuk O, Philip PA, Sarkar FH. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas. 28: e90-5. PMID 15097869 DOI: 10.1097/00006676-200405000-00020 |
0.483 |
|
| 2004 |
Li Y, Ali S, Philip PA, Sarkar FH. Direct comparison of microarray gene expression profiles between non-amplification and a modified cDNA amplification procedure applicable for needle biopsy tissues. Cancer Detection and Prevention. 27: 405-11. PMID 14585328 DOI: 10.1016/S0361-090X(03)00105-3 |
0.311 |
|
| 2004 |
Zhang Y, Banerjee S, Majumdar A, Sarkar F. INHIBITION OF PANCREATIC CANCER CELL GROWTH BY AN E PIDERMAL GROWTH FACTOR R ECEPTOR-R ELATED P ROTEIN (ERRP). Pancreas. 29: 365. DOI: 10.1097/00006676-200411000-00148 |
0.354 |
|
| 2004 |
Wang Z, Zhang Y, Liao D, Sarkar F. NOTCH-1 DOWN REGULATION CONTRIBUTES TO GENISTEIN INDUCED GROWTH INHIBITION AND APO-PTOSIS IN BXPC-3 PANCREATIC CANCER CELLS. Pancreas. 29: 365. DOI: 10.1097/00006676-200411000-00147 |
0.5 |
|
| 2004 |
Banerjee S, Zhang Y, Sarkar F. GENISTEIN POTENTIATED CISPLATIN-INDUCED CYTO-TOXICITY IN HUMAN PANCREATIC CANCER CELLS. Pancreas. 29: 364-365. DOI: 10.1097/00006676-200411000-00146 |
0.375 |
|
| 2004 |
Mohammad R, Wang S, Wu X, Chen J, Min J, Sarkar F. POTENTIATION OF APOPTOSIS INDUCING ACTIVITY OF BL-193, A NONPEPTIDIC SMALL-MOLECULE INHIBITOR OF BCL-2/BCL-XL PROTEINS, BY GENISTEIN IN PANCREATIC CANCER CELLS. Pancreas. 29: 364. DOI: 10.1097/00006676-200411000-00145 |
0.34 |
|
| 2004 |
Mohammad R, Aboukameel A, Kucuk O, Sarkar F. ANTI-TUMOR ACTIVITY OF CISPLATIN IS POTENTIATED BY SOY ISOFLAVONE GENISTEIN IN BXPC-3 PANCREATIC TUMOR XENOGRAFT. Pancreas. 29: 364. DOI: 10.1097/00006676-200411000-00144 |
0.32 |
|
| 2004 |
Banerjee S, Zhang Y, Chiao P, Sarkar F. CISPLATIN-INDUCED CYTOTOXICITY IS ENHANCED BY GENISTEIN IN PANCREATIC CANCER CELLS WITH VARIED METASTATIC POTENTIAL. Pancreas. 29: 364. DOI: 10.1097/00006676-200411000-00143 |
0.409 |
|
| 2003 |
Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J, Wood DP, Kucuk O. Soy isoflavones in the treatment of prostate cancer. Nutrition and Cancer. 47: 111-7. PMID 15087261 DOI: 10.1207/S15327914Nc4702_1 |
0.306 |
|
| 2003 |
Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Investigation. 21: 744-57. PMID 14628433 DOI: 10.1081/Cnv-120023773 |
0.529 |
|
| 2003 |
Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar FH. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene. 22: 4702-9. PMID 12879015 DOI: 10.1038/Sj.Onc.1206583 |
0.483 |
|
| 2003 |
Sarkar FH, Rahman KM, Li Y. Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. The Journal of Nutrition. 133: 2434S-2439S. PMID 12840220 DOI: 10.1093/Jn/133.7.2434S |
0.452 |
|
| 2003 |
Ali S, Aranha O, Li Y, Pettit GR, Sarkar FH, Philip PA. Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1. Cancer Chemotherapy and Pharmacology. 52: 235-46. PMID 12811511 DOI: 10.1007/S00280-003-0628-6 |
0.785 |
|
| 2003 |
Chinni SR, Alhasan SA, Multani AS, Pathak S, Sarkar FH. Pleotropic effects of genistein on MCF-7 breast cancer cells. International Journal of Molecular Medicine. 12: 29-34. PMID 12792805 |
0.433 |
|
| 2003 |
Rahman KM, Aranha O, Sarkar FH. Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells. Nutrition and Cancer. 45: 101-12. PMID 12791510 DOI: 10.1207/S15327914Nc4501_12 |
0.786 |
|
| 2003 |
Marciniak DJ, Moragoda L, Mohammad RM, Yu Y, Nagothu KK, Aboukameel A, Sarkar FH, Adsay VN, Rishi AK, Majumdar AP. Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer. Gastroenterology. 124: 1337-47. PMID 12730874 DOI: 10.1016/S0016-5085(03)00264-6 |
0.369 |
|
| 2003 |
Adsay NV, Merati K, Nassar H, Shia J, Sarkar F, Pierson CR, Cheng JD, Visscher DW, Hruban RH, Klimstra DS. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. The American Journal of Surgical Pathology. 27: 571-8. PMID 12717243 DOI: 10.1097/00000478-200305000-00002 |
0.366 |
|
| 2003 |
Li Y, Li X, Sarkar FH. Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. The Journal of Nutrition. 133: 1011-9. PMID 12672912 DOI: 10.1093/Jn/133.4.1011 |
0.406 |
|
| 2003 |
Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. International Journal of Oncology. 22: 787-94. PMID 12632069 DOI: 10.3892/Ijo.22.4.787 |
0.809 |
|
| 2003 |
Sarkar FH, Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Reviews. 21: 265-80. PMID 12549765 DOI: 10.1023/A:1021210910821 |
0.53 |
|
| 2003 |
Li Y, Sarkar FH. Gene expression profiles of genistein-treated PC3 prostate cancer cells. The Journal of Nutrition. 132: 3623-31. PMID 12468598 DOI: 10.1093/Jn/132.12.3623 |
0.451 |
|
| 2003 |
Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 1087-95. PMID 12379756 DOI: 10.1097/01.Mp.0000028647.98725.8B |
0.333 |
|
| 2003 |
Li Y, Sarkar FH. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Letters. 186: 157-64. PMID 12213285 DOI: 10.1016/S0304-3835(02)00349-X |
0.475 |
|
| 2003 |
Li Y, Sarkar FH. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2369-77. PMID 12114442 |
0.388 |
|
| 2003 |
Chinni SR, Alhasan SA, Multani AS, Pathak S, Sarkar FH. Pleotropic effects of genistein on MCF-7 breast cancer cells. International Journal of Molecular Medicine. 12: 29-34. DOI: 10.3892/Ijmm.12.1.29 |
0.527 |
|
| 2003 |
Sarkar FH, Li Y. Significance of indole-3-carbinol and its metabolite in human cancers Evidence-Based Integrative Medicine. 1: 33-41. DOI: 10.2165/01197065-200301010-00007 |
0.5 |
|
| 2003 |
Marciniak D, Mohammad R, Moragoda L, Yu Y, Aboukameel A, Adsay V, Rishi AK, Sarkar FH, Majumdar AP. Egf-receptor related protein (ERRP): A potential therapeutic agent for colorectal and prostate cancers Gastroenterology. 124: A132. DOI: 10.1016/S0016-5085(03)80652-2 |
0.39 |
|
| 2002 |
Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP. Effects of lycopene supplementation in patients with localized prostate cancer Experimental Biology and Medicine. 227: 881-885. PMID 12424329 DOI: 10.1177/153537020222701007 |
0.373 |
|
| 2002 |
Feng J, Adsay NV, Kruger M, Ellis KL, Nagothu K, Majumdar AP, Sarkar FH. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma. Pancreas. 25: 342-9. PMID 12409827 DOI: 10.1097/00006676-200211000-00004 |
0.322 |
|
| Show low-probability matches. |